Cancer: It’s what’s Best for Business (WW3 – World War Hypocrisy)

David H. Gorski, M.D., Ph.D., F.A.C.S., is a racist and a natural born killer

That’s right !

Dr. Gorski hates #cancer

He’s a bigot when it comes to breast cancer

Gorski sleeps, breathes, and blogs about breast cancer

He is an academic surgical oncologist specializing in breast surgery and oncologic surgery (Surgical Oncology Attending) at the Barbara Ann Karmanos Cancer Institute, Detroit, Michigan specializing in breast cancer surgery, where he also serves as team leader for the Breast Cancer Multidisciplinary Team (MDT) at the Barbara Ann Karmanos Cancer Center, Co-Chair, Cancer Committee, Barbara Ann Karmanos Cancer Center, medical director of the Alexander J. Walt Comprehensive Breast Center at the Barbara Ann Karmanos Cancer Center (2010-present), Co-Leader of the Breast Cancer Biology Program, and the American College of Surgeons Committee on Cancer (ACS CoC) Cancer Liaison Physician as well as Associate Professor of Surgery at the Wayne State University School of Medicine; Faculty (2008-present), and member of the faculty of the Graduate Program in Cancer Biology at Wayne State University, MiBOQI project director (clinical champion) for Karmanos Cancer Center, site project director of the Michigan Breast Oncology Quality Initiative, University of Michigan, Ann Arbor, Michigan, a partnership between Karmanos and the University of Michigan, the new program co-director (Co-Medical Director) of the Michigan Breast Oncology Quality Initiative (MiBOQI); a state-wide initiative to improve the quality of breast cancer care using evidence-based guidelines, serves as the co-director of the Comprehensive Breast Center and is co-leader of the Breast Cancer Biology Program at Karmanos and Wayne State University School of Medicine, a Wayne State University Physician Group surgeon and chief of the Section of Breast Surgery (Breast Surgery Section) for the Wayne State University School of Medicine (2009-present), serves as an associate professor of surgery and Oncology at Wayne State University School of Medicine, Detroit, Michigan, and Treasurer and on the Board of Directors, and also serves the Institute for Science in Medicine as head of its childhood immunization committee

Prior to joining Karmanos and Wayne State University School of Medicine, was an associate professor of surgery at The Cancer Institute of New Jersey and the UMDNJ-Robert Wood Johnson Medical School in New Brunswick, NJ, as well as a member of the Joint Graduate Program in Cell & Developmental Biology at Rutgers University in Piscataway, N.J.

1984 – Graduation with Honors and High Distinction in Chemistry

1994 – MetroHealth Medical Center Resident Research

He attended the University of Michigan Medical School, received his B.S. in chemistry from the University of Michigan, Ann Arbor, Michigan, medical degree (M.D.) from the University of Michigan Medical School, Ann Arbor, Michigan, University of Chicago Fellowship, Surgical Oncology, Case Western Reserve University / University Hospitals Case Medical Center Internship, General Surgery, Case Western: Reserve University / University Hospitals Case Medical Center Residency, General Surgery, and received his Ph.D. in cellular physiology at Case Western Reserve University, Cleveland, Ohio

1998 – American Board of Surgery

Assistant Professor of Surgery UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey

1999 – 2006: Assistant Professor of Surgery

1999 – 2008: Active, Surgical Oncology and General Surgery

2005 – 2006: Active, Surgical Oncology and General Surgery

2007 – American Society of Clinical Oncology Advanced Clinical Research

2007 – Conquer Cancer Foundation of ASCO and Breast Cancer Research Foundation Advanced Clinical Research Award in Breast Cancer

2006 – 2008: Associate Professor of Surgery

Faculty, General Surgery, St. Peter’s University Hospital, New Brunswick, New Jersey

Attending Surgeon, Trauma Services, Lutheran General Hospital, Park Ridge, Illinois

2015 – Michigan State Medical License (Active through)

2015 – Ohio State Medical License (Active through)

Managing Editor of the Science-Based Medicine weblog, as well as a once-weekly contributor

SBM exists to take a skeptical, science-based view of medicine in general and in particular the infiltration of pseudoscientific practices into medicine, even in academic medical centers

These entities must have felt lucky to add a University of Michigan alum to their toolbox, a wolverine; a creature also known as a glutton or skunk bear

Who would doubt that Gorski would be a glutton for punishment when it comes to raising a big stink about breast cancer issues ?

Surely he was aware: Detroit, Michigan; the most populous city in the state of Michigan, with a population of 701,475 (2012) (9,883,360 – Michigan), 575,321 (81.4%) being African American (Black); a little less than six times the national average (82.7% – 2010 / about 83% – 2012) (Michigan – 14.2% – 2010), 369,616 Females (52.7% – 2012 / 53% – 2010) (Michigan 50.9%)

No doubt he knew that the most recent American Cancer Society Cancer Facts & Figures, noted:
——————————————————————
• Studies have documented unequal receipt of prompt, high-quality treatment for African American women compared to white women

• African Americans more likely to be diagnosed at later stage of disease when treatment choices are more limited and less effective

• African Americans and other racial minorities are underrepresented in clinical trials, which makes it more difficult to assess efficacy of cancer therapies among different racial/ethnic groups

• African Americans have highest death rate and shortest survival of any racial and ethnic group in US for most cancers

• Life expectancy lower for African Americans than whites among women (77.2 vs. 80.9 years)

• Higher death rate in African American women compared to white women occurs despite lower cancer incidence rate

• Racial difference in overall cancer death rates is due largely to cancers of the breast and colorectum in women

• African American women have higher death rates overall and for breast and several other cancer sites

• African Americans continue to have lower 5-year survival overall:
69% – whites
60% – African Americans
and for each stage of diagnosis for most cancer sites

• Evidence aggressive tumor characteristics more common in African American than white women
——————————————————————
Gorski worked tirelessly to address the problem, by appearing on TV, radio, Internet radio, in articles and on his blogs

Soon, the locals were remarking about the “Gorski Patient Group” web-site which was set up to display anecdotal stories of breast cancer patients who were “cured” by Gorski

How has his hard work paid off ?
——————————————————————
Are these Dr. David H. Gorski’s “success stories” ?
——————————————————————
African American women breast cancer death rates per 100,000 (MICHIGAN)
—————————————————————–
34.3☝2005_-_2009 (State with 11 most) 2013-2014
33.8👇2003_-_2007 (State with 11 most) 2011-2012
34.7👇2001_-_2005 (State with 17 most) 2009-2010
35.4👇2000_-_2003 (State with 19 most) 2007-2008
36.2👇1997_-_2001 (State tied with 20 most) 2005-2006
——————————————————————
BREAST CANCER
——————————————————————
WHITE-INCIDENCE-MICHIGAN (per 100,000)
——————————————————————
118.7👇2006_-_2010 (2013-2014)
120.1👇2004_-_2008 Incidence (2011-2012)
124.3👇2002_-_2006 (2009-2010)
129.9👇2000_-_2004 (2007-2008)
133.9☝1998_-_2002 (2005-2006)
132.1☝1996_-_2000 (2003-2004)
——————————————————————
WHITE-MORTALITY-MICHIGAN (per 100,000)
——————————————————————
22.8👇2006_-_2010 (2013-2014)
23.4👇2003_-_2007 Mortality (2011-2012)
23.8👇2002_-_2006 (2009-2010)
24.6👇2000_-_2004 (2007-2008)
25.9👇1998_-_2002 (2005-2006)
27.3👇1996_-_2000 (2003-2004)
——————————————————————
AFRICAN AMERICAN-INCIDENCE-MICHIGAN (per 100,000)
——————————————————————
119.4☝2006_-_2010 (2013-2014)
119.2👇2004_-_2008 Incidence (2011_-_2012)
121.0☝2002_-_2006 (2009-2010)
119.0👇2000_-_2004 (2007-2008)
120.6👇1998_-_2002 (2005-2006)
121.4☝1996_-_2000 (2003-2004)
——————————————————————
AFRICAN AMERICAN-MORTALITY-MICHIGAN (per 100,000)
——————————————————————
34.3☝2006_-_2010 (2013-2014)
33.8👇2003_-_2007 Mortality (2011-2012)
34.6👇2002_-_2006 (2009-2010)
35.0👇2000_-_2004 (2007-2008)
36.0👇1998_-_2002 (2005-2006)
36.9👇1996_-_2000 (2003-2004)
——————————————————————
HISPANIC-INCIDENCE-MICHIGAN (per 100,000)
——————————————————————
80.1👇2006_-_2010 (2013-2014)
92.7☝2004_-_2008 Incidence (2011-2012)
——————————————————————
HISPANIC-MORTALITY-MICHIGAN (per 100,000)
——————————————————————
15.8☝2006_-_2010 (2013-2014)
14.26☝2003_-_2007 Mortality (2011-2012)
——————————————————————
INCIDENCE-MICHIGAN (per 100,000) COMBINED
——————————————————————
119.4☝2006_-_2010 AFRICAN AMERICAN (2013-2014)
118.7👇2006_-_2010 WHITE (2013-2014)
80.1👇2006_-_2010 HISPANIC (2013-2014)
——————————————————————
MORTALITY-MICHIGAN (per 100,000) COMBINED
——————————————————————
34.3☝2006_-_2010 AFRICAN AMERICAN (2013-2014)
22.8👇2006_-_2010 WHITE (2013-2014)
15.8☝2006_-_2010 HISPANIC (2013-2014)
——————————————————————
MICHIGAN – Estimated New Breast Cancer Cases:
——————————————————————
8,140☝2013 (State with 8th most)
7,710👇2012 (State with 8th most)
7,890☝2011 (State with 8th most)
7,340☝2010 (State with 8th most)
6,480☝2009 (State with 8th most)
6,120👇2008 (State with 9th most)
7,210👇2005 (State with 9th most)
7,270👇2004 (State with 9th most)
7,500☝2003 (State with 8th most)
7,300☝2002 (State with 8th most)
——————————————————————
Are these Dr. David H. Gorski’s “success stories” ?
——————————————————————
MICHIGAN – Estimated Breast Cancer Deaths:
——————————————————————
1,360☝2013 (State with 8th most)
1,350☝2012 (State with 8th most)
1,320 – 2011 (State with 9th most)
1,320👇2010 (State with 10th most)
1,350☝2009 (State with 9th most)
1,310 👇2008 (State with 9th most)
1,320 👇2007 (State with 9th most)
1,360 👇2006 (State with 9th most)
1,380☝2005 (State with 9th most)
1,350👇2004 (State with 9th most)
1,400 – 2003 (State tied with 8th most)
1,400☝2002 (State tied with 8th most)
——————————————————————
MICHIGAN – Cancer Incidence Rates
——————————————————————
120.3 – 2013 (State with 32nd most)
120.3👇2012 (State with 30th most)
122.2👇2011 (State with 24th most)
124.2👇2010 (State with 17th most)
127.0👇2009 (State with 11th most)
128.8👇2008 (State with 13th most)
129.4👇2007 (State tied with 18th most)
132.4👇2006 (State with 14th most)
133.5☝2005 (State with 13th most)
132.0☝1996_-_2000 (State with 14th most) 2004
129.8☝1995_-_1999 (State with 23rd most)(31st State’s) 2003
109.9👇1994_-_1998 Michigan – Cancer Incidence Rates (2002)
132.0☝1996_-_2000 (State with 14th most) (2004)
129.8☝1995_-_1999 (State with 23rd most) (2003)
109.9☝1994_-_1998 (State with 20th most) (2002)
——————————————————————
MICHIGAN – Cancer Death Rates:
——————————————————————
24.0👇2013 (State tied with 11th most)
24.4👇2012 (State tied with 13th most)
24.5👇2011 (State tied with 16th most)
25.1👇2010 (State tied with 12th most)
25.3👇2009 (State tied with 17th most)
25.8👇2008 (State tied with 18th most)
26.6👇2007 (State tied with 14th most)
27. 5 – 2006 (State tied with 12th most)
27.5👇2005 (State tied with 13th most)
28.4👇1996_-_2000 (State tied with 14th most) (2004)
29.5☝1995_-_1999 (State tied with 14th most) 2003
24.8☝1994_-_1998 (State with 14th most) 2002
——————————————————————
The problem, is that, when the Hippocratic Oath
was mentioned, Gorski may have opted for the Hypocrite Oath

Rather than address the BILLIONS of dollars in fines which Big Pharma racked up, and Pharma’s seeming dedication to getting members of the unwitting public, to take medications for symptoms which they were not approved for; and thus possibly experience adverse effects those drugs cause, Gorski chose to NOT comment about his goose that might lay the golden (parachute) nest egg

Instead, he tried the Tricky-Dicky trickle-down theory of Hackademic Mudicine (“Quackademic Medicine”); which did NOT work when Richard Milhous (“War on Cancer”) Nixon was told:

“There’s a cancer on the Presidency”

What Gorski seems hilariously oblivious to, is that his opprobrium; to turn a phrase, applies to him:
——————————————————————
(.3:16)
——————————————————————
When he mentions:

“ineffective and potentially harmful medical practices that were not, that are not supported by evidence”

he may as well be saying, in regards to surgery, chemotherapy, and radiation:

“ineffective and potentially harmful medical practices that were, that are supported by evidence“

(the evidence that they do NOT work for everyone)
——————————————————————
(.3:42)
——————————————————————
To use his own words, he seems:

“confused, at best”
——————————————————————
(.4:45)
——————————————————————
He also displays:

“an animosity toward reason”
——————————————————————
(.4:49)
——————————————————————
“Nothing’s changed within 30 years

If anything, it’s worse”
——————————————————————
(.6:45)
——————————————————————
He states:

“Alternative = unproved”

There goes “Alternative Rock,” or the “alternative” to an attempted Gorski joke: “happiness is a warm gun”

I’m somewhat surprised that Gorski has yet to classify antineoplastons as “Homeopathy: Ultra-diluted chemotherapy”
——————————————————————
(28:15)
——————————————————————
But he does rant that rival Cleveland Clinic where he had his residency, has been infiltrated by the Q.M.
——————————————————————
(39:10)
——————————————————————
And that his alma-mater, the University of Michigan has also queued in the “Quackademic” line
——————————————————————
(44:00)
——————————————————————
He bemoans the mighty wolverine:

“Again my alma-mater”

“I hang my head in shame”
——————————————————————
(44:10)
——————————————————————
And to add injury to insult, his “former employer,” UMDNJ (University of Medicine and Dentistry of New Jersey)-Robert Wood Johnson Medical School, New Brunswick, New Jersey, has also been bitten by the Quackademic Duck

I’m sure Gorski will be able to formulate a usual factoid #fail for his #failure to “cure” cancer, vis-a-vis “Orac”, the literary Hack, braying in the wilderness and awaiting his Red Badge of Courage

Maybe “too many people copulating” in Detroit, or too many Louisiana hurricane Katrina survivors added to the sandbox

Is Gorski a racist ?

That’s up to all the African American women in Detroit, Michigan, to decide

Maybe he’s just a really bad hypocrite

NOr, maybe he needs to spend less time on the “hypocuresy,” and more time on the “CURE”

Maybe the African American women of Detroit, Michigan, and the United States of America should ask Gorski:

What have you done for me lately ?
——————————————————————

——————————————————————
“And, make no mistake about it, antineoplastons (ANPs) are chemotherapy, no matter how much Burzynski tries to claim otherwise”
——————————————————————
NO, Gorski, the United States’ 5th Circuit Court of Appeals claimed that antineoplastons (ANPs) are:

“…an unapproved drug, not ordinary “chemotherapy”

no matter how much YOU try to claim otherwise

What are you ?

A Saul Green closet communist who does NOT believe what the United States’ Federal Courts rule ?

——————————————————————

——————————————————————
“Indeed, it was a blatant ploy, as Burzynski’s lawyer, Richard Jaffe, acknowledged, referring to one of his clinical trials as a “joke” and the others as a way to make sure there was a constant supply of new cancer patients to the Burzynski Clinic“
——————————————————————

——————————————————————
” … in 1997, his medical practice was expanded to include traditional cancer treatment options such as chemotherapy, gene targeted therapy, immunotherapy and hormonal therapy in response to FDA requirements that cancer patients utilize more traditional cancer treatment options in order to be eligible to participate in the Company’s Antineoplaston clinical trials“

“As a result of the expansion of Dr. Burzynski’s medical practice, the financial condition of the medical practice has improved Dr. Burzynski’s ability to fund the Company’s operations”
——————————————————————
GorskGeek, my citations, references, and / or links, beat your NON-citations, NON-references, and / or NON-links
======================================
AMERICAN CANCER SOCIETY:
CANCER FACTS & FIGURES (2002-2014)
======================================
2002_-_2003 – 1 of every 4 deaths
======================================
Deaths – United States of America
——————————————————————
2013 – almost 1,600 a day
2002-2012☝1,500+ a day
——————————————————————
Expected to Die – United States
——————————————————————
2013☝580,350_-_(3,160 more than 2012)
2012☝577,190_-_(5,240 more than 2011)
2011☝571,950_-_(2,460 more than 2010)
2010☝569,490_-_(7,150 more than 2009)
2009👇562,340_-_(3,310 less than 2008)
2008☝565,650_-_(6,000 more than 2007)
2007👇559,650_-_(5,180 less than 2006)
2006👇564,830_-_(5,450 less than 2005)
2005☝570,280_-_(6,580 more than 2004
2004☝563,700_-_(7,200 more than 2003)
2003☝556,500_-_(6,000 more than 2002)
2002☝555,500
——————————————————————
Estimated All Cancer Deaths (Women)
——————————————————————
2013👇273,430 (1,940 less than 2012)
2012☝275,370 (3,850 more than 2011)
2011☝271,520 (1,230 more than 2010)
2010☝270,290 (490 more than 2009)
2009👇269,800 (1,730 less than 2008)
2008☝271,530 (1,430 more than 2007)
2007👇270,100 (3,460 less than 2006)
2006👇273,560 (1,440 less than 2005)
2005☝275,000 (2,190 more than 2004)
2004☝272,810 (2,210 more than 2003)
2003☝270,600 (3,300 more than 2002)
2002_-_267,300
——————————————————————
Estimated cancer deaths – African Americans expected to die from cancer:
——————————————————————
2013👇64,645 – 22.6% (2013-2014)
2011☝65,540 (About) (2011-2012)
2009☝63,360 (About) (2009-2010)
2007☝62,780 (About) (2007-2008)
——————————————————————
Estimated Breast Cancer Deaths (Women)
——————————————————————
2013☝39,620 (14%) (110 more than 2012)
2012👇39,510 (14%) (10 less than 2011)
2011👇39,520 (15%) (320 less than 2010)
2010👇39,840 (15%) (330 less than 2009)
2009👇40,170 (15%) (310 less than 2008)
2008☝40,480 (15%) (20 more than 2007)
2007👇40,460 (15%) (2007-2008) (510 less than 2006)
2006☝40,970 (15%) (560 more than 2005)
2005☝40,410 (15%) (300 more than 2004)
2004☝40,110 (15%) (310 more than 2003)
2003☝39,800 (15%) (200 more than 2002)
2002 – 39,600 (15%)
——————————————————————
Estimated Deaths from Breast cancer expected to occur among African American women:
——————————————————————
6,080☝2013 – 19% (2013-2014)
6,040☝2011 – 19% (2011-2012)
6,020☝2009 – 19% (2009-2010)
5,830☝2007 – 19% (2007-2008)
5,640☝(2005-2006)
5,640 – 1969-2002 – 18.4% – 2005 (2005-2006)
======================================
New Cancer Cases Expected to be diagnosed – USA
——————————————————————
2013☝1,660,290 – (21,380 more than 2012)
2012☝1,638,910 – (42,240 more than 2011)
2011☝1,596,670 – (67,160 more than 2010)
2010☝1,529,560 – (49,810 more than 2009)
2009☝1,479,350 – (42,170 more than 2008)
2008👇1,437,180 – ( 7,740 less than 2007)
2007☝1,444,920 – (45,130 more than 2006)
2006☝1,399,790 – (26,880 more than 2005)
2005☝1,372,910 – ( 4,870 more than 2004)
2004☝1,368,030 – (33,930 more than 2003)
2003☝1,334,100 – (49,200 more than 2002)
2002☝1,284,900
——————————————————————
Estimated New Cancer All (Women)
——————————————————————
2013☝805,500 – (14,760 more than 2012)
2012☝790,740 – (16,370 more than 2011)
2011☝774,370 – (34,430 more than 2010)
2010☝739,940 – (26,720 more than 2009)
2009☝713,220 – (21,220 more than 2008)
2008☝692,000 – (13,940 more than 2007)
2007👇678,060 – (1,450 less than 2006)
2006☝679,510 – (16,640 more than 2005)
2005👇662,870 – (5,600 less than 2004)
2004☝668,470 – (9,670 more than 2003)
2003☝658,800 – (11,400 more than 2002)
2002_-_647,400
——————————————————————
Estimated New invasive Breast Cancer Cases: (Women)
——————————————————————
2013☝232,340 (29%) (5,470 more than 2012)
2012👇226,870 (29%) (11,610 less than 2011)
2011☝238,480 (30%) (31,390 more than 2010)
2010☝207,090 (28%) (14,720 more than 2009)
2009☝192,370 (27%) (9,910 more than 2008)
2008☝182,460 (26%) (3,980 more than 2007)
2007👇178,480 (26%) (2007-2008) (34,440 less than 2006)
2006☝212,920 (31%) (1,680 more than 2005)
2005👇211,240 (32%) (4,660 less than 2004)
2004☝215,900 (32%) (4,600 more than 2003)
2003☝211,300 (32%) (7,800 more than 2002)
2002_-_203,500 (31%)
——————————————————————
Estimated new cases – new cancer cases expected to be diagnosed among African Americans:
——————————————————————
2013☝176,620 (2013-2014)
2011☝168,900 (About) (2011-2012)
2009👇150,090 (About) (2009-2010)
2008☝182,460 (26%)
2007_-_152,900 (About) (2007-2008)
——————————————————————
Estimated new cases of in situ breast cancer expected to occur:
——————————————————————
64,640☝(2013) (1,340 more than 2012)
63,300☝(2012) (5,650 more than 2011)
57,650☝(2011) (3,640 more than 2010)
54,010👇(2010) (8,270 less than 2009)
62,280👇(2009) (5,490 less than 2008)
67,770☝(2008) (5,740 more than 2007-2008)
62,030☝(2007-2008) (50 more than 2006)
61,980☝(2006) (3,490 more than 2005-2006)
58,490👇(2005-2006) (900 less than 2004)
59,390☝(2004) (3,690 more than 2003)
55,700☝(2003) (1,400 more than 2002)
54,300☝(2002)
——————————————————————
Estimated New Cancer Cases – African Americans – Breast
——————————————————————
2013☝27,060 – 33% (2013-2014)
2011☝26,840 – 34% (2011-2012)
2009☝19,540 – 25% (2009-2010)
2007☝19,010 – 27% (2007-2008)
19,240 – 1979-2001 – 29.9% – 2005 (2005-2006)
——————————————————————
Estimated new cases of in situ breast cancer expected to occur = detection of below # of ductal carcinoma in situ (DCIS):
——————————————————————
54,944 (2013)
85% (2003-2012)
88% (2002)

1998-2002 accounted for about 85% of in situ breast cancers diagnosed (2005-2006)
1980-2001 – Incidence rates of DCIS increased more than sevenfold in all age groups, although greatest in women 50 and older (2005-2006)
——————————————————————
LEADING CAUSE OF DEATH
——————————————————————
2013 – breast cancer expected to be most commonly diagnosed cancer in women
——————————————————————
BREAST CANCER – 2nd
——————————————————————
2013 – Breast cancer 2nd most common cause of cancer death among African American women, surpassed only by lung cancer (2009-2012)
(2007)
——————————————————————
2003 – Breast cancer is 2nd among cancer deaths in women

2002-2003: 2nd leading cause of death

2002 – Breast cancer 2nd leading cause of death
————————————-
Breast cancer most common cancer among African American women

34% – (2011-2012)
25% – (2009-2010)
2007
——————————————————————
2011 – New Cases
(2011-2012)

New Cases: Breast cancer most commonly diagnosed cancer among African American women
——————————————————————
BREAST CANCER – AFRICAN AMERICAN WOMEN
——————————————————————
34% – African American women most common cancer (2011-2012)

African American Women Most common cancer (2005-2006)
——————————————————————
2005 – African American women – more likely to die from at any age
——————————————————————
ESTIMATED WOMEN BREAST CANCER DEATHS
——————————————————————
19% – number of cancer deaths breast cancer in women (2007-2012)
——————————————————————
since 1990 – Death rates from breast cancer steadily decreased in women (2009-2010)

since 1990 – death rate from breast cancer in women decreased (2007-2008)
——————————————————————
1.9% – 2000-2009 cancer mortality rate for women of all races combined declined annually (2012-2013)
——————————————————————
1990-2006 – death rate from breast cancer in women decreased (2005-2006)
——————————————————————
2.2% – 1990-2004 cancer mortality rate for women of all races combined decreased annually (2007-2008)

decline larger among younger age groups (2007-2008)
——————————————————————
2.3% – 1990-2002 rate decreased annually – percentage of decline larger among younger age groups (2005-2006)
——————————————————————
2.3% – 1990-2000 breast cancer death rates decreased annually (2005-2006)
——————————————————————
1992-1998 – mortality rates declined significantly

largest decreases in younger women, both white and black (2002)
——————————————————————
1.6% – 1975-1991 – Breast Cancer Death Rates Increased annually (2005-2006)
——————————————————————
0.4% – 1975-1990 – breast cancer death rates increased annually (2005-2006)
——————————————————————
0.4% – 1975-1990 death rate for all races combined increased annually (2005-2008)
——————————————————————
rate for women of all races combined decreased annually (2007-2008)

decline larger among younger age groups (2007-2008)
——————————————————————
BREAST CANCER – OLDER WOMEN
——————————————————————
Older women much more likely to get breast cancer than younger women
——————————————————————
% FEMALE BREAST CANCER DEATH RATES (age)
——————————————————————
97% – 1998-2002 – age 40 and older (2005-2008)
96% – 1996-2000 – age 40 and older (2005-2006)
——————————————————————
WOMEN YOUNGER than 50
——————————————————————
3.0% – under age of 50 – Mortality from breast cancer declined faster for women (annually from 2005-2009) regardless of race/ethnicity (2013)
——————————————————————
2.3% – 1990-2001 Breast Cancer Death Rates decrease

largest decrease in < 50 (2005-2006)
——————————————————————
3.7% – 1991-2000 under 50 breast cancer Death rates decreased (2005-2006)
——————————————————————
3.3% – 1990-2004 – death rates decreased per year among women younger than 50 (2005c-2008)
——————————————————————
2.3% – 1990-2002 Death rates from breast cancer declined average per year in all women combined, with larger decreases in younger (<50 years) women (2006)
——————————————————————
WOMEN 50 and older
——————————————————————
1.2% – 50 and older – decrease in breast cancer death rates smaller in African American than white women (2009-2010)
——————————————————————
2.0% – 50 and older – 1990-2004 – death rates decreased per year among women (2005-2008)
——————————————————————
WHITE WOMEN
——————————————————————
2.1% – 2000-2009 – breast cancer death rates declined per year in white women
——————————————————————
2.6% – 1992-2000 – breast cancer Death rates Whites (2005-2006)
——————————————————————
2.4% – 1990-2004 female breast cancer death rates declined per year in whites (2005-2008)
——————————————————————
early 1980’s – Breast Cancer Death Rates equal – African American / White (2005-2006)
——————————————————————
AFRICAN AMERICAN WOMEN – ALL CANCERS
——————————————————————
1.5% – since 1999 – Death rates among women (African Americans for all cancers combined) per year have been decreasing (2011-2012)
——————————————————————
AFRICAN AMERICAN WOMEN BREAST CANCER DEATHS
——————————————————————
black women more likely to die of breast cancer than white women (2012-2013)
——————————————————————
2005-2006 African American women more likely to die from breast cancer at every age
——————————————————————
41% – 2005-2009 African American women had higher death rate than white women despite lower incidence rate

39% – 2003-2007 – African American women had higher death rate than white women, despite lower incidence rate (2011-2012)

difference accounts for more than one-third (37%) of overall cancer mortality disparity between African American and white women (2011-2012)

37% – 2001-2005 – African American women had higher death rate than white women (2009-2010)

higher breast cancer mortality rate among African American women compared to white women occurs despite lower incidence rate (2009-2010)

difference accounts for more than one-third (37%) of overall cancer mortality disparity between African American and white women (2009-2010)

higher breast cancer mortality rate among African American women compared to white women occurs despite lower incidence rate (2007)

notable, striking divergence in long-term breast cancer mortality rates trends between African American and white women (2005-2008)

36% – by 2004 – death rates higher in African Americans than white women (2007-2008)
37% – by 2002 – death rates higher in African American women than white women (2005-2006)
36% – 2000-2003 – death rates higher in African American women than white women (2007)

difference accounts for one-third of excess cancer mortality experienced by African American women compared to white women (2007)

32% – 2000 – Breast Cancer Death rate higher in African American women even though had lower incidence rates (2005-2006)
——————————————————————
AFRICAN AMERICAN WOMEN – 50 and older
——————————————————————
1.2% – 50 and older – 1992-2012 – per year – women (2011-2012)

2.0% – 50 and older – Breast Cancer Death Rates – per year (2009-2010)
——————————————————————
1.2% – 50 and older – decrease in breast cancer death rates smaller in African American than white women (2009-2010)

1.1% – 50 and older – 1991-2007 – African American women Breast cancer death rates declined annually (2007)

2.0% – 50 and older – 1990-2000 – breast cancer Death rates decreased (2005-2006)
——————————————————————
1990 – 50 and older – Breast Cancer Death Rates Increase predominantly due to
——————————————————————
AFRICAN AMERICAN WOMEN – under 50
——————————————————————
2.0% – 1992-2012 – decrease larger in women under 50 – declined thereafter per year (2011-2012)

1.9% – 1992-2009 – decrease larger in women under 50 – declined thereafter per year (2009-2010)

resulted in growing disparity

3.3% per year – larger decreases in women younger than 50 – Breast Cancer Death Rates (2009-2010)
——————————————————————
1.9% – 1991_-_2007 – decrease larger in women under 50 – African American women Breast cancer death rates declined annually per year
——————————————————————
AFRICAN AMERICAN WOMEN
——————————————————————
2000-2009 – death among females, rate of decline similar

As result, overall racial disparity narrowed
——————————————————————
2000-2009 death rate declined faster among African Americans females rate of decline than whites

1.5% – 2000-2009 African Americans females rate of decline per year (2013-2014)

1.4% – 2000-2009 whites rate of decline per year (2013-2014 )
——————————————————————
1.4% – 2000-2009 – breast cancer death rates declined more slowly per year in African American women
——————————————————————
1990-2002
African American women benefited less than white women from advances (2005-2008)
——————————————————————
1.1% – breast cancer death rates African Americans (2005-2006)
——————————————————————
1.6% – 1995-2004 – female breast cancer death rates declined per year in African Americans (2007-2008)

1.0% – 1990-2002 female breast cancer death rates declined per year – African Americans (2005-2006)
——————————————————————
early 1990s – Death rates among African Americans for all cancers combined have been decreasing (2011-2012)
——————————————————————
breast cancer death rates have declined more slowly in African American women compared to white women, which has resulted in growing disparity (2011-2012)
——————————————————————
gap much smaller among women
racial difference in overall cancer death rates due largely to cancers of breast and colorectum in women

racial disparity has widened for breast cancer in women (2011-2012)
——————————————————————
early 1980s – disparity in breast cancer death rates between African American and white women began in (2007-2008)
——————————————————————
early 1980s – breast cancer death rates for white and African American women approximately equal (2007)
——————————————————————
30% – early 1980’s-2000 – disparity between African American and white Deaths (2005-2006)
——————————————————————
early 1980s – disparity in breast cancer death rates between African American and white women appeared (2005-2006)
——————————————————————
early 1980s – breast cancer death rates for white and African American women

similar (2011-2014)

equal (2009-2010)

early 1980’s – Breast Cancer Death Rates equal – African American / White (2005-2006)
——————————————————————
1.5% – 1975-1992 – Breast cancer death rates among African American women increased annually (2009-2012)

1.6% – 1975-1991 – African American women Breast cancer death rates increased annually (2007)
——————————————————————
1975-2007 – death rates for all cancers combined continued to be substantially higher among African Americans than whites (2011-2012)
——————————————————————
AFRICAN AMERICAN WOMEN BREAST CANCER DEATH RATE RATIOS per 100,000 women
——————————————————————
35.4 – African American – 1997-2001 – Breast Cancer Death Rate Ratios per 100,000 (2005-2006)

26.4 – White – 1997-2001 – Breast Cancer Death Rate Ratios per 100,000 (2005-2006)

1.3 – African American / White Ratio – 1997-2001 – Breast Cancer Death Rate Ratios per 100,000 (2005-2006)
——————————————————————
HISPANIC / LATINA WOMEN
——————————————————————
2.4% – 1995-2004 female breast cancer death rates declined per year in Hispanics / Latinas (2007-2008)
1.8% – 1990-2002 female breast cancer death rates declined per year in Hispanics / Latinas (2005-2006)
1.4% – breast cancer Death rates Hispanics (2005-2006)

1990-2002
women of other racial and ethnic groups benefited less than white women from advances (2005-2008)
——————————————————————
ASIAN AMERICAN / PACIFIC ISLANDER WOMEN
——————————————————————
1995-2004 female breast cancer death rates remained unchanged among Asian Americans/Pacific Islanders (2007-2008)

1.1% – breast cancer Death rates Asian and Pacific Islanders (2005-2006)

1.0% – 1990-2002 female breast cancer death rates declined per year – Asian Americans / Pacific Islanders (2005-2006)
——————————————————————
1990-2002
women of other racial and ethnic groups benefited less than white women from advances (2005-2008)
——————————————————————
AMERICAN INDIAN / ALASKA NATIVE WOMEN
——————————————————————
1995-2004 female breast cancer death rates remained unchanged among American Indians / Alaska Natives (2007-2008)

1990-2002 female breast cancer death rates did not decline in American Indian / Alaska Natives (2005-2006)
——————————————————————
1990-2002
women of other racial and ethnic groups benefited less than white women from advances (2005-2008)
——————————————————————
breast cancer Death rates American Indian and Alaska Native – constant (2005-2006)
——————————————————————
DEATHS – 2007-2008
——————————————————————
40,460 – Deaths – All ages (2007-2008)
23,510 – Deaths – 65 and older (2007-2008)
16,950 – Deaths – Younger than 65 (2007-2008)
31,320 – Deaths – 55 and older (2007-2008)
9,140 – Deaths – Younger than 55 (2007-2008)
37,630 – Deaths – 45 and older (2007-2008)
2,830 – Deaths – Younger than 45 (2007-2008)
——————————————————————
MORTALITY (DEATH) RATES
——————————————————————
31.0 – Black – Mortality – 1992-1998 – Mortality Rates* by Site, Race, and Ethnicity (2002)

24.3 – White – Mortality – 1992-1998 – Mortality Rates* by Site, Race, and Ethnicity (2002)

14.8 – Hispanic – Mortality – 1992-1998 – Mortality Rates* by Site, Race, and Ethnicity (2002)

12.4 – American Indian / Alaskan Native – Mortality – 1992-1998 – Mortality Rates* by Site, Race, and Ethnicity (2002)

11.0 – Asian / Pacific Islander – Mortality – 1992-1998 – Mortality Rates* by Site, Race, and Ethnicity (2002)
——————————————————————
WHITE WOMEN – MORE LIKELY TO DEVELOP BREAST CANCER
——————————————————————
Combining all age groups, white (non-Hispanic) women more likely to develop breast cancer than black women
——————————————————————
PROBABILITY of DEVELOPING BREAST CANCER in NEXT 10 YEARS (Age)
——————————————————————
20
——————————————————————
20 – 0.05% – 1 in 2,152 – Probability of developing Breast Cancer in next 10 years (2005-2006)
——————————————————————
20 – 0.05% – 1 in 1,985 – 2000-2002 probability of developing breast cancer in next 10 years: † (2005-2006)
——————————————————————
20 – 0.05% – 1 in: 1,837 – probability of developing breast cancer in next 10 years (2007-2008)
——————————————————————
30
——————————————————————
30 – 0.44% – 1 in: 229 (2000-2002) probability of developing breast cancer in next 10 years: † (2005-2006)
——————————————————————
30 – 0.43% – 1 in: 234 – probability of developing breast cancer in next 10 years (2007-2008)
——————————————————————
30 – 0.40% – 1 in 251 – Probability of developing Breast Cancer in next 10 years (2005-2006)
——————————————————————
40
——————————————————————
40 – 1.46% – 1 in: 68 (2000-2002) probability of developing breast cancer in next 10 years: † (2005-2006)
——————————————————————
40 – 1.45% – 1 in 69 – Probability of developing Breast Cancer in next 10 years (2005-2006)
——————————————————————
40 – 1.43% – 1 in: 70 – probability of developing breast cancer in next 10 years (2007-2008)
——————————————————————
50
——————————————————————
50 – 2.78% – 1 in 36 – Probability of developing Breast Cancer in next 10 years (2005-2006)
——————————————————————
50 – 2.73% – 1 in: 37 (2000-2002) probability of developing breast cancer in next 10 years: † (2005-2006)
——————————————————————
50 – 2.51% – 1 in: 40 – probability of developing breast cancer in next 10 years (2007-2008)
——————————————————————
60
——————————————————————
60 – 3.82% – 1 in: 26 (2000-2002) probability of developing breast cancer in next 10 years: † (2005-2006)
——————————————————————
60 – 3.81% – 1 in 26 – Probability of developing Breast Cancer in next 10 years (2005-2006)
——————————————————————
60 – 3.51% – 1 in: 28 – probability of developing breast cancer in next 10 years (2007-2008)
——————————————————————
70
——————————————————————
70 – 4.31% – 1 in 23 – Probability of developing Breast Cancer in next 10 years (2005-2006)
——————————————————————
70 – 4.14% – 1 in: 24 (2000-2002) probability of developing breast cancer in next 10 years: † (2005-2006)
——————————————————————
70 – 3.88% – 1 in: 26 – probability of developing breast cancer in next 10 years (2007-2008)
——————————————————————
LIFETIME RISK
——————————————————————
13.2% – 1 in 8 – 2005-2006 Currently, woman living in US has, or, lifetime risk of developing breast cancer
——————————————————————
13.22% – Lifetime risk – 1 in: 8 – 2000-2002 probability of developing breast cancer in next 10 years: † (2005-2006)
——————————————————————
12.28% – Lifetime risk – 1 in: 8 – probability of developing breast cancer in next 10 years (2007-2008)
——————————————————————
AFRICAN AMERICAN LIFE EXPECTANCY
——————————————————————
2007 – life expectancy lower for African Americans than whites among women

(76.5 vs. 80.6 years) (2011-2012)
——————————————————————
DEVELOPING INVASIVE BREAST CANCER
——————————————————————
1 in 8 – 2013 – chance of developing invasive breast cancer during lifetime
——————————————————————
1 in 8 – 12.3% – Currently, woman living in US has lifetime risk of developing breast cancer (2007-2008)
——————————————————————
about 1 in 11 – 1975
——————————————————————
1 in 11 – 1970s – lifetime risk of being diagnosed with breast cancer (2007-2008)
——————————————————————
result of rounding to nearest whole number, small decrease in lifetime risk (from 1 in 7.47 to 1 in 7.56) led to change in lifetime risk from 1 in 7 previously reported in Breast Cancer Facts & Figures 2003-2004 and Cancer Facts & Figures 2005 to current estimate of 1 in 8

Overall, lifetime risk of being diagnosed with breast cancer gradually increased over past 3 decades (2005-2006)
——————————————————————
INVASIVE BREAST CANCER – by age (2007-2008)
——————————————————————
178,480 – All ages
72,520 – 65 and older
105,960 – Younger than 65
124,300 – 55 and older
54,180 – Younger than 55
162,330 – 45 and older
16,150 – Younger than 45
——————————————————————
INVASIVE BREAST CANCER – by # (2007-2008)
——————————————————————
178,480 – All ages
162,330 – 45 and older
124,300 – 55 and older
105,960 – Younger than 65
72,520 – 65 and older
54,180 – Younger than 55
16,150 – Younger than 45
——————————————————————
INVASIVE BREAST CANCER
——————————————————————
0.3% – 1987-2002 – Incidence Trends: increased per year (2005-2006)
————————————-
—————————–
4% (almost) – 1980-1987 – increased (almost +4% a year) Incidence Trends (2005-2006)
——————————————————————
age 40-49
——————————————————————
Since 1987 – age 40-49 – incidence rates of invasive breast cancer have slightly declined (2005-2006)

3.5% – 40-49 (age) – 1980-1987 – incidence rates of invasive breast cancer increased among women per year – Incidence Trends: Invasive Breast Cancer (2005-2006)
——————————————————————
age 50 and older
——————————————————————
Since 1987 – 50 and older – incidence rates of invasive breast cancer have continued to increase among women, though at much slower rate (2005-2006)

4.2% – 50 and older – incidence rates of invasive breast cancer increased among women per year – Incidence Trends: Invasive Breast Cancer (2005-2006)
——————————————————————
Under 40
——————————————————————
Under 40 – remained essentially constant (2005-2006)

Since 1987 – younger than 40 – relatively little change in incidence rates of invasive breast cancer in women (2005-2006)
——————————————————————
Invasive Breast Cancer
——————————————————————
1975-2000 – Invasive Breast Cancer (2005-2006):

4% – 40 and older – increased 1980-1987 then stabilized (2005-2006)
——————————————————————
1992-2002 – overall incidence rates did not change significantly among whites, African Americans, and Hispanics / Latinas (2005-2006)
——————————————————————
1.3% – Hispanics – increased overall (2005-2006)
——————————————————————
0.9% – Whites – increased overall (2005-2006)
——————————————————————
African Americans – stabilized (2005-2006)
——————————————————————
Asian Americans / Pacific Islanders
——————————————————————
2.1% – 1992-2002 – Asian and Pacific Islanders – overall incidence rates increased overall (2005-2006)

1.5% – 1992-2002 – Asian Americans / Pacific Islanders – overall incidence rates increased per year (2005-2006)

trends in invasive female breast cancer incidence rates (2005-2006)
——————————————————————
American Indian / Alaska Natives
——————————————————————
3.7% – American Indian / Alaska Native – decreased overall (2005-2006)

3.5% – 1992-2002 – American Indian / Alaska Natives – overall incidence rates decreased per year (2005-2006)

trends in invasive female breast cancer incidence rates (2005-2006)
——————————————————————
essentially constant – Incidence Trends
——————————————————————
1973-1980 – essentially constant – Incidence Trends (2005-2006)
——————————————————————
African Americans more likely to be diagnosed at later stage of disease when treatment choices are more limited and less effective (2013-2014)
——————————————————————
MEDIAN AGE of DIAGNOSIS
——————————————————————
62 – median age of diagnosis for -white women
——————————————————————
57 – median age of diagnosis for African American women
——————————————————————
DIAGNOSIS at LOCAL STAGE
——————————————————————
61% – breast cancers diagnosed among white women at local stage (2011-2012)
——————————————————————
51% (Only about half) – of breast cancers diagnosed among African American women are local stage (2011-2014)
——————————————————————
MEDIAN AGE AT TIME OF BREAST CANCER DIAGNOSIS
——————————————————————
61 – 2000_-_2004 median age at time of breast cancer diagnosis (2007-2008)
61 – 1998_-_2002 median age at time of breast cancer diagnosis
——————————————————————
61 – means 50% of women who developed breast cancer were 61 or younger (2007-2008)
50% of women who developed breast cancer were age 61 or younger 1998_-_2002
——————————————————————
61 – 50% were older than 61 when diagnosed (2007-2008)

50% were older than age 61 when diagnosed 1998_-_2002
——————————————————————
2005_-_2009 % / age DIAGNOSED with BREAST CANCER
——————————————————————
61 – median age for breast cancer diagnosis

0.0% – under age 20
1.8% – between 20-34
9.9% – between 35-44
22.5% – between 45-54
24.8% – between 55-64
20.2% – between 65-74
15.1% – between 75-84
5.7% – 85+
——————————————————————
2005_-_2009 % / age DIAGNOSED with BREAST CANCER by % (SEER, 2012)
——————————————————————
24.8% – between 55-64
22.5% – between 45-54
20.2% – between 65-74
15.1% – between 75-84
9.9% – between 35-44
5.7% – 85+
1.8% – between 20-34
0.0% – under age 20
——————————————————————
IN SITU BREAST CANCER – by age (2007-2008)
——————————————————————
62,030 – All ages
21,510 – 65 and older
40,520 – Younger than 65
37,110 – 55 and older
24,920 – Younger than 55
54,390 – 45 and older
7,640 – Younger than 45
——————————————————————
IN SITU BREAST CANCER – by # (2007-2008)
——————————————————————
62,030 – All ages
54,390 – 45 and older
40,520 – Younger than 65
37,110 – 55 and older
24,920 – Younger than 55
21,510 – 65 and older
7,640 – Younger than 45
——————————————————————
NEW CASES – IN SITU BREAST CANCER
——————————————————————
increase observed in all age groups, although greatest in women 50 and older (2007-2008)
——————————————————————
Since 2000 – incidence rates of in situ breast cancer leveled off among women 50 and older (2007-2008)
——————————————————————
Since 2000 – incidence rates of in situ breast cancer have continued to increase in younger women (2007-2008)
——————————————————————
80% – 2000-2004 – Most in situ breast cancers are ductal carcinoma (DCIS), which accounted for about 80% of in situ breast cancers diagnosed (2007-2008)
——————————————————————
2000-2004 – Lobular carcinoma in situ (LCIS) less common than DCIS, accounting for about 10% of female in situ breast cancers diagnosed (2007-2008)

Similar to DCIS, overall incidence rate of LCIS increased more rapidly than incidence of invasive breast cancer (2007-2008)

increase limited to women older than age 40 and largely to postmenopausal women (2007-2008)
——————————————————————
1998-2002 accounting for female in situ breast cancers diagnosed (2005-2006):

12% – Lobular carcinoma in situ (LCIS) less common than DCIS

Similar to DCIS, overall incidence rate of LCIS increased more rapidly than incidence of invasive breast cancer

increase limited to women older than 40 and largely to postmenopausal women
——————————————————————
1980s and 1990s – Incidence rates of in situ breast cancer increased rapidly (2007-2008)
——————————————————————
New cancer cases in women expected to be newly diagnosed among African Americans:
——————————————————————
2013 – 82,080 (About)
——————————————————————
19% – breast cancer in women (2007-2008)
——————————————————————
2002 – Breast cancer ranks 2nd among cancer deaths in women
——————————————————————
2002-2003: 2nd leading cause of death
——————————————————————
African American women expected to die from cancer:
——————————————————————
African Americans have the highest death rate and shortest survival of any racial and ethnic group in the US for most cancers
(2007-2014)
African Americans have the highest mortality rate of any racial and ethnic group in the US for most cancers
(2005-2006)
——————————————————————
higher death rate in African
American women compared to white women occurs despite lower cancer incidence rate (2013-2014)
——————————————————————
African American women have higher death rates overall and for breast and several other cancer sites (2013-2014)
——————————————————————
15% – 2009 – death rate for all cancers combined continued to be higher in African American women than in white women (2013-2014)
——————————————————————
racial difference in overall cancer death rates is due largely to cancers of the breast and colorectum in women (2013-2014)
——————————————————————
overall racial disparity in cancer death rates decreasing (2013-2014)
——————————————————————
16% – 2007 – death rate for all cancers combined higher in African American women than white women (2011-2012)
——————————————————————
37% – by 2002 – death rates higher in African Americans than white women (2005-2006)
——————————————————————
since early 1990s – death rates among African Americans for all cancers combined have been decreasing (2013-2014)
——————————————————————
30% – early 1980’s–2000 – Deaths disparity between African American and white (2005–2006)
——————————————————————
1975-2009 – Despite declines, death rates for all cancers combined continued to be higher among African Americans than whites (2013-2014)
——————————————————————
1992-2014 – Breast cancer death rates among African American women declined
——————————————————————
1.4% per year – 2000-2009 – breast cancer death rates declined more slowly in African American women
——————————————————————
2.1% per year – 2000-2009 – breast cancer death rates declined white women
——————————————————————
early 1980s – breast cancer death rates for white and African American women similar
——————————————————————
1975-1992 – Breast cancer death rates among African American women increased
resulted in growing disparity
——————————————————————
through 1998 – breast cancer incidence rates among young white women continued to increase more slowly (2002)
——————————————————————
1980s – 4.5% per year increase (2002)
——————————————————————
As result, overall racial disparity narrowed (2013-2014)
——————————————————————
1992-1998 – mortality rates declined significantly – largest decreases in younger women, both white and black (2002)
——————————————————————
1992-1998 – Incidence and Mortality Rates* by Site, Race, and Ethnicity (2002)
——————————————————————
Incidence
——————————————————————
115.5 – White
101.5 – Black
78.1 – Asian / Pacific Islander
50.5 – American Indian / Alaskan Native
68.5 – Hispanic
——————————————————————
Mortality
——————————————————————
31.0 – Black
24.3 – White
14.8 – Hispanic
12.4 – American Indian / Alaskan Native
11.0 – Asian / Pacific Islander
——————————————————————
Cancer Facts & Figures for African Americans 2005-2006
——————————————————————
1995-2000 (2001) – Diagnosed
Female breast (2005-2006):
——————————————————————
Localized
——————————————————————
64% – White (2005-2006)
53% – African American (2005-2006)
——————————————————————
Regional
——————————————————————
35% – African American (2005-2006)
28% – White (2005-2006)
——————————————————————
Distant
——————————————————————
9% – African American (2005-2006)
5% – White (2005-2006)
——————————————————————
Unstaged
——————————————————————
3% – African American (2005-2006)
2% – White (2005-2006)
——————————————————————
2005-2006 – Cancer Incidence Rates Ratios per 100,000 (1975-2001)
——————————————————————
1997-2001 – Breast (2005-2006)
143.2 – White (2005-2006)
118.6 – African American (2005-2006)
0.8 – African American / White Ratio (2005-2006)
——————————————————————
2005-2006 – Cancer Death Rate Ratios per 100,000
——————————————————————
1997-2001 – Breast (2005-2006)
35.4 – African American (2005-2006)
26.4 – White (2005-2006)
1.3 – African American / White Ratio (2005-2006)
——————————————————————
Most common cancer among African American Women (2005-2006)
——————————————————————
17% lower incidence rate in African American than White (2005-2006)
——————————————————————
under 40 – higher incidence rate in African American than White (2005-2006)
——————————————————————
25 years incidence:
——————————————————————
1999-2001 – leveling off (2005-2006)
1986-1999 – less rapid increase (2005-2006)
1978-1986 – rapid increase (2005-2006)
1975-1978 – stable (2005-2006)
——————————————————————
Breast Cancer Death Rates Increased (2005-2006):
——————————————————————
1975-1991 – + 1.6% – annually (2005-2006)
——————————————————————
1991 – decided annually: particularly in women younger than 50 (2005-2006)
——————————————————————
Breast Cancer Death Rates (2005-2006):
——————————————————————
early 1980’s – equal – African American / White (2005-2006)
——————————————————————
2000 – 32% – higher African American (2005-2006)
——————————————————————
Death rate higher in African American even though had lower incidence rates (2005-2006)
——————————————————————
Rate per 100,000
——————————————————————
White
African American
Asian or Pacific Islander
Hispanic
American Indian or Alaska Native
——————————————————————
1996-2000 – Incidences:

140.8 – White
121.7 – African American
97.2 – Asian or Pacific Islander
89.8 – Hispanic
58 – American Indian or Alaska Native
——————————————————————
1996-2000 – Deaths

35.9 – African American
27.2 – White
17.9 – Hispanic
14.9 – American Indian or Alaska Native
12.5 – Asian or Pacific Islander
——————————————————————
Estimated New In Situ Cases:
——————————————————————
2003_-_100 – < 30
2005 – 1,600 – Under 40
2003 – 2,100 – 30-39
2005 – 56,890 – 40 and older
2005 – 13,760 – Under 50
2003 -12,600 – 40-49
2005 – 44,730 – 50 and older
2005 – 37,040 – Under 65
2003 – 15,700 – 50-59
2005 – 21,450 – 65 and older
2003 – 11,500 – 60-69
2003 – 10,100 – 70-79
2003 – 3,500 – 80 +
2005 – 58,490 – All ages
TOTAL
2003 – 55,700
——————————————————————
2003_-_100 – 0.2%
2003 – 2,100 – 3.8%
2003 – 12,600 – 22.6%
2003 – 15,700 – 28.2%
2003 – 11,500 – 20.6%
2003 – 10,100 – 18.1%
2003 – 3,500 – 16.3
TOTAL
2003 – 100.0%
——————————————————————
Estimated New Invasive Cases:
——————————————————————
2003 – 1,000 – < 30
2005 – 9,510 – Under 40
2003 – 10,500 – 30-39
2005_-_201,730 – 40 and older
2005 – 45,780 – Under 50
2003 – 35,500 – 40-49
2005_-_165,460 – 50 and older
2005_-_123,070 – Under 65
2003 – 48,700 – 50-59
2005 – 88,170 – 65 and older
2003 – 43,100 – 60-69
2003 – 45,600 – 70-79
2003 – 27,000 – 80 +
2005_-_211,240 – All ages
TOTAL
2003 – 55,700 –
——————————————————————
2003 – 1,000 – 0.5%
2003 – 10,500 – 5.0%
2003 – 35,500 – 16.8%
2003 – 48,700 – 23.0%
2003 – 43,100 – 20.4%
2003 – 45,600 – 21.6%
2003 – 27,000 – 12.8%
TOTAL
2003 – 100.00%
——————————————————————
Deaths:
——————————————————————
2003_-_100 – < 30
2005 – 1,110 – Under 40
2003 – 1,300 – 30-39
2005 – 39,300 – 40 and older
2005 – 5,590 – Under 50
2003 – 4,300 – 40-49
2005 – 34,820 – 50 and older
2005 – 17,470 – Under 65
2003 – 7,000 – 50-59
2005 – 22,940 – 65 and older
2003 – 7,400 – 60-69
2003 – 9,500 – 70-79
2003 – 10,100 – 80 +
2005 – 40,410 – All ages
TOTAL
2003 – 39,800
——————————————————————
2003_-_100 – 0.3%
2003 – 1,300 – 3.3%
2003 – 4,300 – 10.8%
2003 – 7,000 – 17.6 %
2003 – 7,400 – 18.6%
2003 – 9,500 – 23.9%
2003 – 10,100 – 25.4%
TOTAL
2003 – 100.0
——————————————————————
1990 – Increase since predominantly due to women 50 and older
——————————————————————
1998-2002 accounting for female in situ breast cancers diagnosed (2005-2006):
——————————————————————
12% – Lobular carcinoma in situ (LCIS) less common than DCIS

Similar to DCIS, overall incidence rate of LCIS increased more rapidly than incidence of invasive breast cancer

increase limited to women older than 40 and largely to postmenopausal women
——————————————————————
1990-2001 (2005-2006):
——————————————————————
2.3% – decrease
largest decrease in < 50
——————————————————————
1998-2002 women aged 40 and older (2005-2006):
——————————————————————
95% – new cases
97% – breast cancer deaths
——————————————————————
1996-2000 Women 40 and older (2005-2006):
——————————————————————
94% – New Cases
96% – Deaths
——————————————————————
0.3% per year – Incidence rates declined slightly among white females (2013-2014)
——————————————————————
1996-2002 (2005-2006):
——————————————————————
20-24 – 1.3 per 100,000 lowest incidence rate – 1998-2002 (2005-2006)

20-24 – 1.4 per 100,000 lowest incidence rate – 1996-2000 (2005-2006)
——————————————————————
75-79 – 496.6 per 100,000 highest incidence rate – 1998-2002 (2005-2006)

75-79 – 499.0 per 100,000 highest incidence rate – 1996-2000 (2005-2006)
——————————————————————
2005-2006
•
White women higher incidence of breast cancer than African American women after 35

African American women slightly higher incidence rate before 35

African American women more likely to die from breast cancer at every age
——————————————————————
2005

White – higher incidence rate than African American women after 40

African American – slightly higher incidence rate before 40

African American women – more likely to die from at any age
——————————————————————
2005-2006 incidence and death rates from breast cancer lower among women of other racial and ethnic groups than white and African American women
——————————————————————
2000-2009 – stable among African American females (2013-2014)
——————————————————————
1975-1980 essentially constant (2005-2006)
1980-1987 + almost 4% per year (2005-2006)
1987-2002 + 0.3% per year (2005-2006)
•
Incidence Trends
Invasive Breast Cancer (2005-2006):

1973-1980 – essentially constant (2005-2006)
1980-1987 – + almost 4% year (2005-2006)
1987-2000 – 0.4% year (2005-2006)
——————————————————————
1980-1987 incidence rates of invasive breast cancer increased among women (2005-2006):
——————————————————————
40-49 (3.5% per year) (2005-2006)
50 and older (4.2% per year) (2005-2006)
Since 1987
50 and older – rates have continued to increase among women , though at much slower rate (2005-2006)

40-49 -rates have slightly declined (2005-2006)

younger than 40 – relatively little change in incidence rates of invasive breast cancer in women (2005-2006)

1975-2000 – Invasive Breast Cancer (2005-2006):

4% – 40 and older increased 1980 – 1987 then stabilized (2005-2006)

Under 40 – remained essentially constant (2005-2006)
——————————————————————
2005-2006 trends in invasive female breast cancer incidence rates:
——————————————————————
1992-2002
(1.5% per year) – overall incidence rates increased in Asian Americans / Pacific Islanders (2005-2006)

(3.5% per year) – decreased in American Indian/Alaska Natives (2005-2006)

did not change significantly among whites, African Americans, and Hispanics/Latinas (2005-2006)

1992-2000 – Invasive (2005-2006):

2.1% – Asian and Pacific Islanders – increased overall (2005-2006)
1.3% – Hispanics – increased overall (2005-2006)
0.9% – Whites – increased overall (2005-2006)
3.7% – American Indian and Alaska Native – decreased overall (2005-2006)
——————————————————————
African Americans – stabilized (2005-2006)
——————————————————————
since 1990 – death rate from breast cancer in women decreased (2005-2006)
——————————————————————
1975-1990
0.4% – death rate for all races combined increased annually (2005-2006)
•
1990-2002
2.3% – rate decreased annually
percentage of decline larger among younger age groups (2005-2006)

1990-2002
3.3% – death rates decreased per year among women younger than 50 (2005-2006)

2.0% – per year among women 50 and older (2005-2006)

African American women and women of other racial and ethnic groups have benefited less than white women from advances (2005-2006)

1990-2002 female breast cancer death rates declined (2005-2006):

2.4% – per year – whites (2005-2006)
1.8% – per year – Hispanics/Latinas (2005-2006)
1.0% – per year – African Americans and Asian Americans/Pacific Islanders (2005-2006)

did not decline in American Indian/ Alaska Natives (2005-2006)
——————————————————————
life expectancy lower for African Americans than whites among women (77.2 vs. 80.9 years) (2013-2014)
——————————————————————
As result, overall racial disparity narrowed (2013-2014)
——————————————————————
striking divergence in long-term mortality trends between African American and white females (2005-2006)
——————————————————————
early 1980s – disparity in breast cancer death rates between African American and white women appeared (2005-2006)
——————————————————————
1975-1990 – Death (2005-2006):
0.4% – increased annually (2005-2006)
——————————————————————
1990-2000
2.3% – decreased annually (2005-2006)
——————————————————————
1991-2000
3.7% – under 50 decreased (2005-2006)
——————————————————————
1990-2000
2.0% – 50 and older decreased (2005-2006)
——————————————————————
1992-2000 – Death (2005-2006):
——————————————————————
2.6% – Whites (2005-2006)
1.4% – Hispanics (2005-2006)
1.1% – African Americans (2005-2006)
1.1% – Asian and Pacific Islanders (2005-2006)
American Indian and Alaska Native – constant (2005-2006)
——————————————————————
Probability of developing Breast Cancer in next 10 years:
——————————————————————
Age
——————————————————————
20 – 0.05% – 1 in 2,152 (2005-2006)
20 – 0.05% – 1 in 1,985 – 2000-2002 (2005-2006)†
——————————————————————
30 – 0.40% – 1 in 251 (2005-2006)
30 – 0.44% – 1 in: 229 – 2000-2002 (2005-2006)†
——————————————————————
40 – 1.45% – 1 in 69 (2005-2006)
40 – 1.46% – 1 in: 68 – 2000-2002 (2005-2006)†
——————————————————————
50 – 2.78% – 1 in 36 (2005-2006)
50 – 2.73% – 1 in: 37 – 2000-2002 (2005-2006)†
——————————————————————
60 – 3.81% – 1 in 26 (2005-2006)
60 – 3.82% – 1 in: 26 – 2000-2002 (2005-2006)†
——————————————————————
70 – 4.31% – 1 in 23 (2005-2006)
70 – 4.14% – 1 in: 24 – 2000-2002 (2005-2006)†
——————————————————————
Lifetime Probability (%) of Developing or Dying from Invasive Cancers by Race and Sex
——————————————————————
Developing

12.73 (1 in 8) – White (%) 2007-2009 (2013-2014)

10.87 (1 in 9) – African American (%) 2007-2009 (2013-2014)

Dying

3.25 (1 in 31) – African American (%) 2007-2009 (2013-2014)

2.73 (1 in 37) – White (%) 2007-2009 (2013-2014)

2005-2006 Currently, woman living in US has 13.2%, or 1 in 8, lifetime risk of developing breast cancer (2013-2014)

result of rounding to nearest whole number, small decrease in lifetime risk (from 1 in 7.47 to 1 in 7.56) led to change in lifetime risk from 1 in 7 previously reported in Breast Cancer Facts & Figures 2003-2004 and Cancer Facts & Figures 2005 to current estimate of 1 in 8

2005-2006: Overall, lifetime risk of being diagnosed with breast cancer gradually increased over past 3 decades (2013-2014)
——————————————————————
13.22% – Lifetime risk – 1 in: 8
Comparison of Cancer Incidence Rates between African Americans and Whites
——————————————————————
123.2 – White Rate* 2005-2009 (2013-2014)
121.7 – White Rate* 2003-2007 (2011-2012)
130.6 – White Rate* 2001-2005 +
——————————————————————
118.1 – African American Rate* 2005-2009 (2013-2014)
114.7 – African American Rate* 2003-2007 (2011-2012)
117.6 – African American Rate* 2001-2005 +
——————————————————————
-5.1 – Difference† 2005-2009 (2013-2014)
-7.0 – Absolute Difference† 2003-2007 (2011-2012)
-13.1 – Absolute Difference† 2001-2005 +
——————————————————————
0.96 – Rate Ratio‡ 2005-2009 (2013-2014)
0.94 – Rate Ratio‡ 2003-2007 (2011-2012)
0.90 – Rate Ratio‡ 2001-2005 +

*Rates per 100,000 age adjusted to 2000 US standard population

†Difference is rate in African Americans minus rate in whites

†Absolute difference is rate in African Americans minus rate in whites

‡Rate ratio is unrounded rate in African Americans divided by unrounded rate in whites

‡Rate ratio is rate in African Americans divided by rate in whites based on 2 decimal places

+ Source: Surveillance, Epidemiology, and End Results (SEER) Program, 17 SEER Registries 2000-2005, Division of Cancer Control and Population Sciences, National Cancer Institute, 2008
——————————————————————
Comparison of Cancer Death Rates between African Americans and Whites
——————————————————————
31.6 – African American Rate* 2005-2009
32.4 – African American Rate* 2003-2007 (2011-2012)
33.5 – African American Rate* 2001-2005 +
——————————————————————
22.4 – White Rate* 2005-2009
23.4 – White Rate* 2003-2007 (2011-2012)
24.4 – White Rate* 2001-2005 +
——————————————————————
9.2 – Difference† 2005-2009
9.0 – Absolute Difference† 2003-2007 (2011-2012)
9.1 – Absolute Difference† 2001-2005 +
——————————————————————
1.41 – Rate Ratio‡ 2005-2009
1.39 – Rate Ratio‡ 2003-2007 (2011-2012)
1.37 – Rate Ratio‡ 2001-2005 +

*Rates per 100,000 and age adjusted to 2000 US standard population

†Difference is rate in African Americans minus rate in whites

†Absolute difference is rate in African Americans minus rate in whites

‡Rate ratio is unrounded rate in African Americans divided by unrounded rate in whites

‡Rate ratio is rate in African Americans divided by rate in whites based on 2 decimal places

+ Source: Surveillance, Epidemiology, and End Results (SEER) Program, 17 SEER Registries 2000-2005, Division of Cancer Control and Population Sciences, National Cancer Institute, 2008
——————————————————————
Stage Distribution for Selected Cancers in African Americans and Whites

Stage Distribution African Americans and Whites
——————————————————————
Localized
——————————————————————
61% – White 2002-2008
61% – White 1999-2006
62% – White 1996-2004 +
——————————————————————
51% – African American 2002-2008
51% – African American 1999-2006
51% – African American 1996-2004 +
——————————————————————
Regional

38% – African American 2002-2008
39% – African American 1999-2006
37% – African American 1996-2004 +
——————————————————————
32% – White 2002-2008
32% – White 1999-2006
31% – White 1996-2004 +
——————————————————————
Distant
——————————————————————
8% – African American 2002-2008
8% – African American 1999-2006
10% – African American 1996-2004 +
——————————————————————
5% – White 2002-2008
5% – White 1999-2006
6% – White 1996-2004 +
——————————————————————
Unstaged
——————————————————————
3% – African American 2002-2008
3% – African American 1999-2006
3% – African American 1996-2004 +
——————————————————————
2% – White 2002-2008
2% – White 1999-2006
2% – White 1996-2004 +
——————————————————————
+ Source:
Surveillance, Epidemiology, and End Results (SEER) Program, 17 SEER Registries, 1973-2005, Division of Cancer Control and Population Sciences, National Cancer Institute, 2008
——————————————————————
Probability of Developing Invasive Cancers Over Selected Age Intervals among African Americans by Sex +

Probability of Developing Invasive Cancers:
——————————————————————
Birth to 39 (%):
——————————————————————
0.53 (1 in 189) 2003-2005 * +
0.44 (1 in 229) 1998–2000 (2004)
0.44 (1 in 228) 1997–1999 (2003)
0.44 (1 in 229) 1996–1997 (2002)
——————————————————————
40 to 59(%):
——————————————————————
3.56 (1 in 28) – 40 to 59(%) 2003-2005 * +
4.14 (1 in 24) 1998–2000 (2004)
4.17 (1 in 24) 1997–1999 (2003)
4.17 (1 in 24) 1996–1997 (2002)

2.96 (1 in 34) – 60 to 69 (%) 2003-2005 * +
——————————————————————
60 to 79 (%):
——————————————————————
7.53 (1 in 13) 1998–2000 (2004)
7.14 (1 in 14) 1997–1999 (2003)
7.14 (1 in 14) 1996–1997 (2002)

5.44 (1 in 18) – 70 and Older (%) 2003-2005 * +
——————————————————————
Birth to Death (%)
——————————————————————
9.91 (1 in 10) – Birth to Death (%) 2003-2005 * +
13.36 (1 in 7) 1998–2000 (2004)
13.3 (1 in 8) 1997–1999 (2003)
12.5 (1 in 8) 1996–1997 (2002)

*For people free of cancer at beginning of age interval

+ Source:
DevCan:
Probability of Developing or Dying of Cancer Software, Version 6.3.0. Statistical Research and Applications Branch, National Cancer Institute, 2008
——————————————————————
2005-2006 Currently, woman living in US has 13.2%, or 1 in 8, lifetime risk of developing breast cancer (2013-2014)

result of rounding to nearest whole number, small decrease in lifetime risk (from 1 in 7.47 to 1 in 7.56) led to change in lifetime risk from 1 in 7 previously reported in Breast Cancer Facts & Figures 2003-2004 and Cancer Facts & Figures 2005 to current estimate of 1 in 8
——————————————————————
2005-2006: Overall, lifetime risk of being diagnosed with breast cancer gradually increased over past 3 decades (2013-2014)
——————————————————————
5-YEAR SURVIVAL RATE – ALL
——————————————————————
Survival after diagnosis of breast cancer continues to decline after 5 years (2009-2010)

Survival after diagnosis of breast cancer continues to decline beyond 5 years (2006)
——————————————————————
5-YEAR RELATIVE SURVIVAL LOWER
——————————————————————
5-year relative survival lower among women with more advanced stage at diagnosis (2007-2008)

5-year relative survival lower among women with more advanced stage of disease at diagnosis (2005-2006)
——————————————————————
2005-2006 African American women with breast cancer less likely than white women to survive 5 years:
——————————————————————
90% – white
76% – African American
——————————————————————
Likely to survive 5 years (2005-2006):
——————————————————————
88% – White
74% – African American
——————————————————————
5-YEAR SURVIVAL RATE – ALL STAGES – COMBINED
——————————————————————
89% – survival rate at 5 years for all stages combined (2009-2010)
——————————————————————
88% – all stages combined – 5 year
——————————————————————
77% – all stages combined – 10 year
——————————————————————
5-YEAR RELATIVE SURVIVAL RATE for ALL CANCERS COMBINED
——————————————————————
63% – 2004
62% – 2002-2003
——————————————————————
5-year Relative Survival Rates* for Cancers by Race and Stage

Five-year Relative Survival Rates* for Cancers by Race and Stage at Diagnosis

Five-Year Relative Survival Rates

5-year Relative Survival Rates (1995-2000 (2001) diagnosed) SEER 1975–2001 (2004)
——————————————————————
Localized
——————————————————————
99% – White 2002-2008 (2013-2014)
61% – White 1999-2006 (2011-2012)
99% – White 1996-2004 +
98% – White 1995–2000 (2005–2006)
——————————————————————
93% – African American 2002-2008 (2013-2014)
51% – African American 1999-2006 (2011-2012)
93% – African American 1996-2004 +
91% – African American 1995–2000 (2005–2006)
——————————————————————
Regional
——————————————————————
85% – White 2002-2008 (2013-2014)
32% – White 1999-2006 (2011-2012)
85% – White 1996-2004 +
82% – White 1995–2000 (2005–2006)
——————————————————————
73% – African American 2002-2008 (2013-2014)
39% – African American 1999-2006 (2011-2012)
72% – African American 1996-2004 +
68% – African American 1995–2000 (2005–2006)
——————————————————————
Distant
——————————————————————
25% – White 2002-2008 (2013-2014)
5% – White 1999-2006 (2011-2012)
29% – White 1996-2004 +
27% – White 1995–2000 (2005–2006)
——————————————————————
15% – African American 2002-2008 (2013-2014)
8% – African American 1999-2006 (2011-2012)
17% – African American 1996-2004 +
15% – African American 1995–2000 (2005–2006)
——————————————————————
All Stages
——————————————————————
90% – White 2002-2008 (2013-2014)
2% – White 1999-2006 (2011-2012)
90% – White 1996-2004 +
56% – White 1995–2000
(2005–2006)
——————————————————————
78% – African American 2002-2008 (2013-2014)
3% – African American 1999-2006 (2011-2012)
77% – African American 1996-2004 +
50% – African American 1995–2000 (2005-2006)
——————————————————————
*Survival rates based on patients diagnosed 2002-2008 followed through 2009

*Survival rates based on patients diagnosed 1999-2006 followed through 2007

Survival rates based on patients diagnosed 1996 – 2004 followed through 2005 +

Local:
invasive cancer confined entirely to organ of origin

Regional:

malignant cancer either

1) extended beyond limits of organ of origin directly into surrounding organs or tissues

2) involves regional lymph nodes by way of lymphatic system

3) both regional extension and involvement of regional lymph nodes

Distant:

malignant cancer spread to parts of body remote from primary tumor either by direct extension or by discontinuous metastasis to distant organs, tissues, or via lymphatic system to distant lymph nodes

+ Source:
Surveillance, Epidemiology, and End Results (SEER) Program, 17 SEER Registries, 1973-2005, Division of Cancer Control and Population Sciences, National Cancer Institute, 2008
——————————————————————
Considering all races, 5-year relative survival:

98% – localized disease
81% – regional disease
26% – distant-stage disease

Larger tumor size at diagnosis associated with decreased survival
among women of all races with regional disease, 5-year relative survival:

92% – tumors less than or equal to 2.0 cm
77% – tumors 2.1-5.0 cm
65% – tumors greater than 5.0 cm
——————————————————————
OVERALL 5-YEAR CANCER SURVIVAL RATE (2005-2006)
——————————————————————
55% – 1995-2000 (2005-2006)
27% – 1960-1963 (2005-2006)
——————————————————————
5-YEAR RELATIVE SURVIVAL RATES
——————————————————————
89% – 5 year relative survival rates for women diagnosed with breast cancer after diagnosis (2007-2008)
88% – 5 year relative survival rates for women diagnosed with breast cancer after diagnosis (2005-2006)
87% – 5 year Breast Cancer Survival Rates after Diagnosis (2005-2006)
——————————————————————
age 75 + – 5 year relative survival rate among women diagnosed with breast cancer
——————————————————————
88% – 75 and older (2005-2006)
86% – 75 and over (2005-2006)
——————————————————————
age 65 + – 5 year relative survival rate among women diagnosed with breast cancer
——————————————————————
89% – 65-74 (2005-2006)
88% – 65 and over (2005-2006)
——————————————————————
5-year relative survival rate among women diagnosed with breast cancer
——————————————————————
88% – 55-64 (2005-2006)
89% – 40-74 (2005-2006)
87% – 45-54 (2005-2006)
83% – 45 (less than) (2005-2006)
——————————————————————
40 and older – 5-year relative survival rate
——————————————————————
89% – 40 and older – 5-year relative survival rate slightly lower among women diagnosed with breast cancer (2007-2008)
——————————————————————
younger than 40 – 5-year relative survival rate
——————————————————————
82% – before 40 – slightly lower among women diagnosed with breast cancer (2007-2008)
——————————————————————
82% – younger than 40 – slightly lower among women diagnosed with breast cancer before age 40 – may be due to tumors in age group being more aggressive (2005-2006)
——————————————————————
All – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis
——————————————————————
86% – 1992-1997 (2002) – 1974-1997
78% – 1983-1985 (2002) – 1974-1997
75% – 1974-1976 (2002) – 1974-1997
——————————————————————
WHITE WOMEN
——————————————————————
69% – white women (2013-2014)
——————————————————————
62% – white women (2007)
——————————————————————
90% – 1999-2006 white women (2011-2012)
——————————————————————
90% – 1996-2004 white women – 5-year relative survival rate for breast cancer diagnosed (2009-2010)
——————————————————————
90% – white women with breast cancer to survive 5 years (2007-2008)
——————————————————————
5-year survival greater among white women (2007)
——————————————————————
90% – 2002-2008 – overall 5-year relative survival rate for breast cancer diagnosed among white women
——————————————————————
88% – White women – Likely to survive 5 years (2005-2006)
——————————————————————
81% – White women – 5 year survivors: relative 5 year survival rate (2005-2006)
——————————————————————
62% – 1996-2004 – white women – 5-year relative survival rate for breast cancer diagnosed (2009-2010)
——————————————————————
90% – 1996-2002 – whites (2007) – 1974-1997 – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis (2002)
——————————————————————
90% – 1996-2002 – White – 5-Year Relative Survival – Breast 2007 (2007-2008) +
——————————————————————
89% – 1995-2000 – White – 5-year Relative Survival (1995-2000 (2001) Diagnosis) SEER 1975-2001 (2004) (2005-2006)
——————————————————————
87% – 1992-1997 – White – 1974-1997 – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis (2002)
——————————————————————
79% – 1983-1985 – White – 1974-1997 – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis (2002)
——————————————————————
75% – 1974-1976 – White – 1974-1997 – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis (2002)
——————————————————————
AFRICAN AMERICAN WOMEN
——————————————————————
78% – black women still living 5 years after getting disease (SEER, 2012)
——————————————————————
78% – 1999-2006 – 5-year relative survival rate for breast cancer diagnosed among African American women Survival and Stage at Distribution (2011-2012)
——————————————————————
76% – African American – 5 year survivors relative 5 year survival rate (2005-2006)
——————————————————————
74% – African American – Likely to survive 5 years (2005-2006)
——————————————————————
60% – African Americans – continue to have lower 5-year survival than whites overall and for each stage of diagnosis for most cancer sites (2013-2014)

African Americans continue to be less likely than whites to survive 5 years at each stage of diagnosis for most cancer sites (2009-2010)

Within each stage, 5-year survival also lower among African American women (2009-2010)

78% – 2002-2008 – overall 5-year relative survival rate for breast cancer diagnosed among African American women

77% – African American women with breast cancer less likely than white women to survive 5 years (2007-2008)
76% – African American women with breast cancer less likely than white women to survive 5 years 2005-2006

60% – 2002-2008 – overall 5-year relative survival rate among African Americans improved (2013-2014)

59% – 1999-2006 – African Americans continue to be less likely than whites to survive 5 years at each stage of diagnosis for most cancer sites (2011-2012)

58% – 1996-2004 – overall 5-year relative survival rate among African Americans improved (2009-2010)

77% – 1996-2002 – 5-Year Relative Survival – Breast – African American 2007 (2007-2008) +
77% – 1996-2002 – African American women (2007) – 1974-1997 – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis (2002)

72% – 1992-1997 – Black – 1974-1997 – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis (2002)

63% – 1983-1985 – Black – 1974-1997 – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis (2002)

63% – 1974-1976 – Black – 1974-1997 – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis (2002)

27% – 1960-1963 – overall 5-year relative survival rate among African Americans improved (2009-2014)
——————————————————————
1996-2002 – 5-Year Relative Survival – Breast 2007 – (Based on cancer patients diagnosed 1996-2002 followed through 2003) (2007-2008) +

(Source: Surveillance, Epidemiology, and End Results (SEER) Program, 17 SEER Registries, 1975-2003, Division of Cancer Control and Population Sciences, National Cancer Institute, 2006) (2007-2008)
——————————————————————
relative survival rates for women diagnosed with breast cancer (2005-2006):
•
88% – 5 years after diagnosis (2005-2006)
80% – 10 years (2005-2006)
71% – 15 years (2005-2006)
63% – 20 years (2005-2006)
•
Breast Cancer Survival Rates after Diagnosis:
•
87% – 5 years (2005-2006)
77% – 10 years (2005-2006)
63% – 15 years (2005-2006)
52% – 20 years (2005-2006)
——————————————————————
2005-2006 – 5-year relative survival rate slightly lower among women diagnosed with breast cancer before age 40
•
may be due to tumors in age group being more aggressive and less responsive to hormonal therapy:
•
82% – younger than 40 (2005-2006)
89% – 40 – 74 (2005-2006)
88% – 75 and older (2005-2006)
•
5 year relative survival rate (2005-2006):
•
83% – < 45
87% – 45 – 54
88% – 55 – 64
89% – 65 – 74
88% – 65 and over
86% – 75 and over
——————————————————————
5 year survivors
relative 5 year survival rate (2005-2006):
•
81% – White
76% – African American
——————————————————————
10 year survivors after diagnosis
relative 5 year survival rate (2005-2006):
——————————————————————
87% – White
85% – African American
——————————————————————
LOCALIZED CANCER INCIDENCE RATES RATIOS per 100,000 (1975-2001) – 1995-2000 (2001) – Diagnosed Female breast (2005-2006): Localized – Of all breast cancers diagnosed 2005-2006
——————————————————————
143.2 – White
118.6 – African American

0.8 – African American / White Ratio
——————————————————————
2005-2006
1995-2000 – 5-year Relative Survival (1995-2000 (2001) Diagnosis) SEER 1975-2001 (2004)
89% – White (2005-2006)
75% – African American (2005-2006)
——————————————————————
2005-2006
1995-2000 – 5-year Relative Survival Rates (1995-2000 (2001) diagnosed) SEER 1975-2001 (2004)
Female breast
——————————————————————
Localized
——————————————————————
98% – White (2005-2006)
91% – African American (2005-2006)
——————————————————————
Regional
——————————————————————
82% – White (2005-2006)
68% – African American (2005-2006)
——————————————————————
Distant
——————————————————————
27% – White (2005-2006)
15% – African American (2005-2006)
——————————————————————
Unstaged
——————————————————————
56% – White (2005-2006)
50% – African American (2005-2006)
——————————————————————
LOCALIZED 5-YEAR RELATIVE SURVIVAL RATES (1995-2000 (2001) diagnosed) SEER 1975-2001 (2004) Female breast (2005-2006)
——————————————————————
98% – 1995-2000 – White
91% – 1995-2000 – African American
——————————————————————
LOCALIZED
——————————————————————
98% – 2010 – 5-year relative survival for localized breast cancer (malignant cancer that has not spread to lymph nodes or other locations outside breast) has increased (2009-2010)

98% – localized disease: 5-year relative survival – Considering all races (2007-2008)

98% – 2006 – 5-year relative survival for localized breast cancer (cancer not spread to lymph nodes or other locations outside breast) increased

98% – localized disease – 2005-2006 5-year relative survival lower among women with more advanced stage of disease at diagnosis: Considering all races

98% – 2005 – 5 year relative survival for localized

97% – 2004 – 5-year relative survival for localized breast cancer (cancer not spread to lymph nodes or other locations outside breast) increased

96% – 2002 – 5-year relative survival for localized breast cancer (cancer not spread to lymph nodes or other locations outside breast) increased

99% – 1996-2002 White – localized (2007-2008) *

94% – 1996-2002 African American – localized (2007-2008) *

80% – 1950s – 5-year relative survival for localized breast cancer (malignant cancer that has not spread to lymph nodes or other locations outside breast) has increased (2009-2010)

80% – 1950s – 5-year relative survival for localized breast cancer (cancer not spread to lymph nodes or other locations outside breast) increased (2006)

72% – 1940s – 5-year relative survival rate for localized breast cancer (cancer not spread to lymph nodes or other locations outside breast) increased (2002)
——————————————————————
5-year relative survival rate for breast cancer diagnosed at local stage
——————————————————————
77% – 1996-2004 – African American women – 5-year relative survival rate for breast cancer diagnosed at local stage (2009-2010)
——————————————————————
LOCALIZED
——————————————————————
62% – 1996-2002 White – Localized – Stage Distribution – Female breast (2007-2008)

64% – White – Localized (2005–2006)

64% – 1995-2000 (2001) – White: Diagnosed Female breast (2005-2006): Localized – Of all breast cancers diagnosed

5% – 1995-2000 (2001) – White: Diagnosed Female breast (2005-2006): Localized – Of all breast cancers diagnosed

52% – 1996-2002 African American – Localized – Stage Distribution – Female breast (2007-2008)

53% – African American – Localized (2005–2006)

53% – 1995-2000 (2001) – African American: Diagnosed Female breast (2005-2006): Localized – Of all breast cancers diagnosed
——————————————————————
REGIONAL 5-YEAR RELATIVE SURVIVAL RATES (1995-2000 (2001) diagnosed) SEER 1975-2001 (2004) Female breast (2005-2006)
——————————————————————
82% – 1995-2000 – White
68% – 1995-2000 – African American
——————————————————————
REGIONALLY
——————————————————————
84% – cancer spread regionally, current 5-year survival (2009-2010)

84% – regional disease – 5-year relative survival: Considering all races (2007-2008)

81% – regional disease – 5-year relative survival lower among women with more advanced stage of disease at diagnosis: Considering all races 2005-2006

85% – 1996-2002 White – Regional (2007-2008) *

80% – cancer spread regionally

78% – 2002 – 5-year relative survival rate: breast cancer spread regionally

72% – 1996-2002 African American – Regional (2007-2008) *
——————————————————————
36% – 1996-2002 African American – Regional: Stage Distribution – Female breast (2007-2008)

30% – 1996-2002 White – Regional: Stage Distribution – Female breast (2007-2008)

35% – African American – Regional (2005–2006)

35% – 1995-2000 (2001) – African American: Diagnosed
Female breast (2005-2006): Regional – Of all breast cancers diagnosed

28% – White – Regional (2005–2006)
——————————————————————
REGIONAL TUMORS
——————————————————————
94% – Larger tumor size at diagnosis also associated with decreased survival among women of all races with regional disease, 5-year relative survival for tumors less than or equal (2007-2008)

92% – tumors less than or equal to 2.0 cm – Larger tumor size at diagnosis associated with decreased survival among women of all races with regional disease, 5-year relative survival

77% – tumors 2.1-5.0 cm – Larger tumor size at diagnosis associated with decreased survival among women of all races with regional disease, 5-year relative survival

65% – tumors greater than 5.0 cm – Larger tumor size at diagnosis associated with decreased survival among women of all races with regional disease, 5-year relative survival
——————————————————————
DISTANT
——————————————————————
27% – women with distant spread (metastases) 5-year survival (2009-2010)

27% – 1995-2000 – White – Distant 5-year Relative Survival Rates (1995-2000 (2001) diagnosed) SEER 1975-2001 (2004) Female breast (2005-2006)

27% – distant-stage disease: 5-year relative survival, Considering all races (2007-2008)

26% – distant metastasis

26% – distant-stage disease – 2005-2006 5-year relative survival lower among women with more advanced stage of disease at diagnosis: Considering all races

28% – 1996-2002 White – Distant (2007-2008) *

21% – 2002 – 5-year relative survival rate: breast cancer distant metastasis

16% – 1996-2002 African American – Distant (2007-2008) *

15% – 1995-2000 – African American – Distant 5-year Relative Survival Rates (1995-2000 (2001) diagnosed) SEER 1975-2001 (2004) Female breast (2005-2006)

28% – 1995-2000 (2001) – White: Distant – Diagnosed Female breast (2005-2006): Of all breast cancers diagnosed
——————————————————————
9% – 1996-2002 African American – Distant – Stage Distribution African Americans – Female breast (2007-2008)

9% – African American – Distant (2005–2006)

9% – 1995-2000 (2001) – African American: Diagnosed
Female breast (2005-2006): Localized – Of all breast cancers diagnosed

6% – 1996-2002 White – Distant – Stage Distribution Whites – Female breast (2007-2008)

5% – White – Distant (2005–2006)
——————————————————————
UNSTAGED
——————————————————————
56% – 1996-2002 – Unstaged – White (2007-2008) *

56% – 1995-2000 – White – Unstaged 5-year Relative Survival Rates (1995-2000 (2001) diagnosed) SEER 1975-2001 (2004) Female breast (2005-2006)

50% – 1995-2000 – Unstaged – African American – 5-year Relative Survival Rates (1995-2000 (2001) diagnosed) SEER 1975-2001 (2004) Female breast (2005-2006)

45% – 1996-2002 – Unstaged – African American (2007-2008) *
——————————————————————
3% – 1996-2002 African American – Unstaged – Stage Distribution Whites – Female breast (2007-2008)

3% – African American – Unstaged (2005–2006)

3% – 1995-2000 (2001) – African American: Unstaged – Of all breast cancers diagnosed – Diagnosed
Female breast (2005-2006)

2% – 1996-2002 White – Unstaged – Stage Distribution Whites – Female breast (2007-2008)

2% – White – Unstaged (2005–2006)

2% – 1995-2000 (2001) – White: Diagnosed Female breast (2005-2006): Unstaged – Of all breast cancers diagnosed
——————————————————————
ALL – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis
——————————————————————
90% – 1999-2006 (2011) – 1975-2006
87% – 1992-1999 (2004)
87% – 1992-1999 (2004) – 1974-1999
86% – 1974-1998 (2003)
86% – 1992-1998 (2003) – 1974-1998
86% – 1992-1997 (2002) – 1974-1997
79% – 1984-1986 (2011) – 1975-2006
78% – 1983-1985 (2004)
78% – 1983-1985 (2004) – 1974-1999
78% – 1983-1985 (2002) – 1974-1997
75% – 1975-1977 (2011) – 1975-2006
78% – 1974-1998 (2003)
75% – 1974-1976 (2004)
75% – 1974-1976 (2004) – 1974-1999
75% – 1974-1976 (2002) – 1974-1997
——————————————————————
WHITE WOMEN – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis
——————————————————————
91% – 1999-2006 (2011) – 1975-2006
90% – 1996-2002 (2007)
88% – 1992-1999 (2004)
88% – 1992-1999 (2004) – 1974-1999
88% – 1992-1998 (2003) – 1974-1998
88% – 1974-1998 (2003)
87% – 1992-1997 (2002) – 1974-1997
81% – 1984-1986 (2011) – 1975-2006
79% – 1983-1985 (2004)
79% – 1983-1985 (2004) – 1974-1999
79% – 1983-1985 (2002) – 1974-1997
76% – 1975-1977 (2011) – 1975-2006
75% – 1974-1976 (2004)
75% – 1974-1976 (2004) – 1974-1999
75% – 1974-1976 (2002) – 1974-1997
——————————————————————
AFRICAN AMERICAN WOMEN – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis
——————————————————————
78% – 1999-2006 (2011) – 1975-2006
77% – 1996-2002 (2007)
74% – 1992-1999 (2004)
74% – 1992-1999 (2004) – 1974-1999
73% – 1992-1998 (2003) – 1974-1998
73% – 1974-1998 (2003)
72% – 1992-1997 (2002) – 1974-1997
65% – 1984-1986 (2011) – 1975-2006
64% – 1983-1985 (2004)
64% – 1983-1985 (2004) – 1974-1999
63% – 1983-1985 (2002) – 1974-1997
63% – 1974-1998 (2003)
63% – 1974-1976 (2004)
63% – 1974-1976 (2004) – 1974-1999
63% – 1974-1976 (2002) – 1974-1997
62% – 1975-1977 (2011) – 1975-2006
——————————————————————
COMBINED – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis
——————————————————————
91% – 1999-2006 – White Women – 1975-2006 (2011)
90% – 1999-2006 – All – 1975-2006 (2011)
90% – 1996-2002 – White Women (2007)
87% – 1992-1997 – White Women – 1974-1997 (2002)
86% – 1992-1997 – All – 1974-1997 (2002)
81% – 1984-1986 – White Women – 1975-2006 (2011)
79% – 1984-1986 – All – 1975-2006 (2011)
79% – 1983-1985 – White Women – 1974-1997 (2002)
78% – 1999-2006 – African American Women – 1975-2006 (2011)
78% – 1983-1985 – All – 1974-1997 (2002)
77% – 1996-2002 – African American Women (2007)
76% – 1975-1977 – White Women – 1975-2006 (2011)
75% – 1975-1977 – All – 1975-2006 (2011)
75% – 1974-1976 – All – 1974-1997 (2002)
75% – 1974-1976 – White Women – 1974-1997 (2002)
72% – 1992-1997 – African American Women – 1974-1997 (2002)
65% – 1984-1986 – African American Women – 1975-2006 (2011)
63% – 1983-1985 – African American Women – 1974-1997 (2002)
63% – 1974-1976 – African American Women – 1974-1997 (2002)
62% – 1975-1977 – African American Women – 1975-2006 (2011)
——————————————————————
COMBINED by YEAR – 1974-1997 – Trends in 5-Year Relative Survival Rates* by Race and Year of Diagnosis
——————————————————————
91% – 1999-2006 – White Women – 1975-2006 (2011)
90% – 1999-2006 – All – 1975-2006 (2011)
78% – 1999-2006 – African American Women – 1975-2006 (2011)
——————————————————————
90% – 1996-2002 – White Women (2007)
77% – 1996-2002 – African American Women (2007)
——————————————————————
87% – 1992-1997 – White Women (2002)
86% – 1992-1997 – All (2002)
72% – 1992-1997 – African American Women (2002)
——————————————————————
81% – 1984-1986 – White Women – 1975-2006 (2011)
79% – 1984-1986 – All – 1975-2006 (2011)
65% – 1984-1986 – African American Women – 1975-2006 (2011)
——————————————————————
79% – 1983-1985 – White Women (2002)
78% – 1983-1985 – All (2002)
63% – 1983-1985 – African American Women (2002)
——————————————————————
76% – 1975-1977 – White Women – 1975-2006 (2011)
75% – 1975-1977 – All – 1975-2006 (2011)
62% – 1975-1977 – African American Women – 1975-2006 (2011)
——————————————————————
75% – 1974-1976 – All (2002)
75% – 1974-1976 – White Women (2002)
63% – 1974-1976 – African American Women (2002)
——————————————————————
Stages (%) – 5-Year Relative Survival Rates by Stage at Diagnosis
——————————————————————
97.0% – 1992-1999 – Local (2004)
97% – 1992-1998 – Local (2003)
96% – 1992-1997 – Local (2002)
——————————————————————
88% – 2006 – All Stages (2006)
86.6% – 1992-1999 – All Stages (2004)
86% – 1992-1998 – All Stages (2003)
86% – 1992-1997 – All Stages (2002)
——————————————————————
81% – Regional (2006)
78.7% – 1992-1999 – Regional (2004)
78% – 1992-1998 – Regional (2003)
78% – 1992-1997 – Regional (2002)
——————————————————————
26% – 2006 – distant metastases (2006)
23.3% – 1992-1999 – Distant (2004)
23% – 1992-1998 – Distant (2003)
21% – 1992-1997 – Distant metastases (2002)
——————————————————————
*
——————————————————————
1996-2002 – 5-Year Relative Survival Rates (5-year relative survival rate among cancer patients diagnosed 1996-2002 followed through 2003) *

Female breast – (Source: Surveillance, Epidemiology, and End Results (SEER) Program, 17 SEER Registries, 1973-2003, Division of Cancer Control and Population Sciences, National Cancer Institute, 2006) (2007-2008)

Local:

invasive cancer confined entirely to organ

Regional:

malignant cancer

1) extended beyond limits of organ of origin directly into surrounding organs or tissues

2) involves regional lymph nodes by way of lymphatic system

3) has both regional extension and involvement of regional lymph nodes

Distant:

cancer spread to parts of body remote from primary tumor either by direct extension or by discontinuous metastasis to distant organs, tissues, or via lymphatic system to distant lymph nodes

Source:

Surveillance, Epidemiology, and End Results (SEER) Program, 17 SEER Registries, 1975-2003, Division of Cancer Control and Population Sciences, National Cancer Institute, 2006 (2007-2008)
——————————————————————
5-YEAR SURVIVAL – INVASIVE BREAST CANCER
——————————————————————
90% – 2002-2008 – women diagnosed with invasive breast cancer still living 5 years after getting disease (SEER, 2012)
——————————————————————
10-YEAR SURVIVAL RATES
——————————————————————
Caution should be used when interpreting 10-year survival rates since they represent detection and treatment circumstances 5-17 years ago and may underestimate expected survival based on current conditions (2009-2010)

Caution should be used when interpreting long-term survival rates since they reflect experience of women treated using past therapies and do not reflect recent trends in early detection or advances in treatment (2007-2008)
——————————————————————
87% – White – 10 year survivors after diagnosis relative 5 year survival rate (2005-2006)
——————————————————————
85% – African American – 10 year survivors after diagnosis relative 5 year survival rate (2005-2006)
——————————————————————
81% – 10 year – relative survival rates for women diagnosed with breast cancer (2007-2008)
——————————————————————
80% – 10 year – survival rate for all stages combined (2009-2010)
——————————————————————
80% – 10 years after diagnosis – relative survival rates for women diagnosed with breast cancer (2005-2006)
——————————————————————
77% – 10 year – Breast Cancer Survival Rates after Diagnosis (2005-2006)
——————————————————————
15-YEAR SURVIVAL RATE
——————————————————————
73% – 15 year – relative survival rates for women diagnosed with breast cancer (2007-2008)
——————————————————————
71% – 15 years after diagnosis – relative survival rates for women diagnosed with breast cancer (2005-2006)
——————————————————————
63% – 15 years – Breast Cancer Survival Rates after Diagnosis (2005-2006)
——————————————————————
20-YEAR SURVIVAL RATE
——————————————————————
63% – 20 years after diagnosis – relative survival rates for women diagnosed with breast cancer (2005-2006)
——————————————————————
52% – 20 years – Breast Cancer Survival Rates after Diagnosis (2005-2006)
======================================
Breast Cancer
American Cancer Society
Cancer Facts & Figures (2002-2014)
======================================
REFERENCES:
======================================
[A] – .7/30/2013, Tuesday – Karmanos Cancer Center’s Dr. David Gorski appointed program co-director of Michigan Breast Oncology Quality Initiative:
——————————————————————
http://www.karmanos.org/News/Default.aspx?sid=1&nid=359
======================================
[B] – .7/30/2013 – Dr. Gorski named co-director of Michigan Breast Oncology Quality Initiative:
——————————————————————
http://prognosis.med.wayne.edu/article/dr-gorski-named-codirector-of-michigan-breast-oncology-quality-initiative
======================================
[C] – 07/30/2013 – Dr. Gorski named co-director of Michigan Breast Oncology Quality Initiative : ——————————————————————
http://www.wsupgdocs.org/news-and-media/WayneStateContentPage.aspx?nd=1293&news=515
======================================
[D] – 2/1/2011 – Barbara Ann Karmanos Cancer Center Names Dr. David Gorski Leader of Breast Multidisciplinary Team:
/PRNewswire-USNewswire/ — The Barbara Ann Karmanos Cancer Center has named David Gorski, M.D., Ph.D., leader of the Breast Multidisciplinary Team (MDT), effective Tuesday, Feb. 1
——————————————————————
http://m.prnewswire.com/news-releases/barbara-ann-karmanos-cancer-center-names-dr-david-gorski-leader-of-breast-multidisciplinary-team-115018114.html
======================================
[E] – 11/2/2011, Wednesday – Make the Right Move:
——————————————————————
http://www.karmanos.org/News/breast-cancer-specialists
======================================
[F]
——————————————————————
http://cancerbiologyprogram.med.wayne.edu/faculty/gorski.php
======================================
[G] – Research Interest:
——————————————————————
http://www.wsusurgery.com/research-team-dr-gorski/
======================================
[H]
——————————————————————
http://wsusurgery.com/facultyc3/david-gorski/
——————————————————————
http://www.wsusurgery.com/facultyc3/david-gorski/
======================================
[I]
——————————————————————
http://wsusurgery.com/research-team-dr-gorski/
——————————————————————
http://www.wsusurgery.com/research-team-dr-gorski/
======================================
[J]
——————————————————————
http://karmanos.org/Physicians/Details.aspx?sid=1&physician=70
——————————————————————
http://www.karmanos.org/Physicians/Details.aspx?sid=1&physician=70
======================================
[K]
——————————————————————
http://sciencebasedmedicine.org/editorial-staff/
——————————————————————
http://www.sciencebasedmedicine.org/editorial-staff/
======================================
[L]
——————————————————————
http://www.scienceinmedicine.org/fellows/GorskiD.html
——————————————————————
http://scienceinmedicine.org/fellows/GorskiD.html
======================================
[M]
——————————————————————
http://sciencebasedmedicine.org/editorial-staff/david-h-gorski-md-phd-managing-editor/
——————————————————————
http://www.sciencebasedmedicine.org/editorial-staff/david-h-gorski-md-phd-managing-editor/
======================================
[N]
——————————————————————
http://scienceblogs.com/insolence
======================================
[O]
——————————————————————
http://ncas.org/2013/02/mar-9-david-h-gorski-quackademic.html?m=1
——————————————————————
http://www.ncas.org/2013/02/mar-9-david-h-gorski-quackademic.html?m=1
======================================
[P]
——————————————————————
http://whybiotech.com/?p=3808
——————————————————————
http://www.whybiotech.com/?p=3808
======================================
[Q]
——————————————————————
http://en.wikipedia.org/wiki/David_Gorski
======================================
[R] – Breast Cancer Research – Dr. Gorski:
——————————————————————
http://www.wsusurgery.com/breast-cancer-research-dr-gorski/
======================================
[S] – Selected Publications:
——————————————————————
http://www.wsusurgery.com/selected-publications-dr-gorski/
======================================
[T] – Lab Photos:
——————————————————————
http://www.wsusurgery.com/lab-photos-dr-gorski/
======================================
[U]
——————————————————————
https://www.doximity.com/pub/david-gorski-md
======================================
[V] – Detroit, Michigan population
——————————————————————
http://www.worldpopulationstatistics.com/detroit-population-2013/
======================================
[W]
——————————————————————
http://quickfacts.census.gov/qfd/states/26/2622000.html
======================================
[X]
——————————————————————
http://www.city-data.com/city/Detroit-Michigan.html
======================================
[Y] – 11/13/2013 – The War on Cancer (I don’t think it means, what you think it says it means) #Winning?:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/11/13/httpcancer-orgacsgroupscontentepidemiologysurveilancedocumentsdocumentacspc-036845-pdf/
======================================
[Z] – 3/9/2013 – Quackademic Medicine: How pseudoscience is infiltrating medical academia.”
——————————————————————
http://m.youtube.com/watch?v=mewOSMNgfGQ&desktop_uri=%2Fwatch%3Fv%3DmewOSMNgfGQ
======================================
[]
——————————————————————
http://www.nixonlibrary.gov/forresearchers/find/tapes/excerpts/watergate.php
——————————————————————
http://whitehousetapes.net/transcript/nixon/cancer-presidency
——————————————————————
http://m.washingtonpost.com/politics/cancer-on-the-presidency/2012/06/08/gJQAp24LOV_video.html
——————————————————————
http://www.history.com/speeches/nixon-and-dean-discuss-watergate
======================================
2013-2014 Breast Cancer Facts & Figures
——————————————————————

Click to access acspc-040951.pdf

——————————————————————

Click to access acspc-040951.pdf

——————————————————————
2013-2014 Cancer Facts & Figures for African Americans
——————————————————————

Click to access acspc-036921.pdf

——————————————————————

Click to access acspc-036921.pdf

——————————————————————
2012-2014 Cancer Facts & Figures for Hispanics / Latinos
——————————————————————

Click to access acspc-034778.pdf

——————————————————————

Click to access acspc-034778.pdf

======================================
2013 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013
——————————————————————
2013-2014 Cancer Facts & Figures
——————————————————————

Click to access acspc-040951.pdf

——————————————————————

Click to access acspc-040951.pdf

——————————————————————

——————————————————————
http://onlinelibrary.wiley.com/doi/10.3322/caac.21203/full
——————————————————————
2013
——————————————————————

Click to access breast-cancer-facts-2012.pdf

——————————————————————

Click to access breast-cancer-facts-2012.pdf

——————————————————————
2012-2013 Survivorship
——————————————————————

Click to access acspc-033876.pdf

——————————————————————

Click to access acspc-033876.pdf

——————————————————————
2013 – Cancer Facts & Figures
——————————————————————

Click to access acspc-036845.pdf

——————————————————————

Click to access acspc-036845.pdf

——————————————————————
2013 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index
======================================
2011-2012 Breast Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/breast-cancer-facts-and-figures-2011-2012
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/breast-cancer-facts-and-figures-2011-2012
——————————————————————
Breast Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/breast-cancer-facts-figures
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/breast-cancer-facts-figures
——————————————————————
2012 – Cancer Facts & Figures
——————————————————————

Click to access acspc-031941.pdf

——————————————————————

Click to access acspc-031941.pdf

——————————————————————
2012 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/index
——————————————————————
2012 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012
——————————————————————
2011-2012 Cancer Facts & Figures for African Americans
——————————————————————

Click to access acspc-027765.pdf

——————————————————————

Click to access acspc-027765.pdf

======================================
2011 – Cancer Facts & Figures
——————————————————————

Click to access acspc-029771.pdf

——————————————————————

Click to access acspc-029771.pdf

——————————————————————
2011 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2011
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2011
——————————————————————
2009-2011 Cancer Facts & Figures for Hispanics / Latinos
——————————————————————

Click to access ffhispanicslatinos20092011.pdf

——————————————————————

Click to access ffhispanicslatinos20092011.pdf

======================================
2010
——————————————————————
http://cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/breast-cancer-facts-figures-2009-2010
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/breast-cancer-facts-figures-2009-2010
——————————————————————
2009-2010 Breast Cancer Facts & Figures
——————————————————————

Click to access f861009final90809pdf.pdf

——————————————————————

Click to access f861009final90809pdf.pdf

——————————————————————
2010 – Cancer Facts & Figures
——————————————————————

Click to access acspc-024113.pdf

——————————————————————

Click to access acspc-024113.pdf

——————————————————————
2010 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2010/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2010/index
——————————————————————
2009-2010 Cancer Facts & Figures for African Americans
——————————————————————

Click to access cffaa20092010pdf.pdf

——————————————————————

Click to access cffaa20092010pdf.pdf

======================================
2009
——————————————————————
http://www.komenstlouis.org/site/DocServer/DiversityAsianPacific.pdf?docID=222
——————————————————————
2009-2010 Cancer Facts & Figures for African Americans
——————————————————————

Click to access cffaa20092010pdf.pdf

——————————————————————

Click to access cffaa20092010pdf.pdf

——————————————————————
2009 – Cancer Facts & Figures
——————————————————————

Click to access 500809webpdf.pdf

——————————————————————

Click to access 500809webpdf.pdf

——————————————————————
2009 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2009/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2009/index
——————————————————————
2009 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2009
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2009
======================================
Breast Cancer Facts & Figures
——————————————————————
http://www.cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/
——————————————————————
2007-2008 Breast Cancer Facts & Figures
——————————————————————

Click to access bcfffinalpdf.pdf

——————————————————————

Click to access bcfffinalpdf.pdf

——————————————————————
Cancer Facts and Statistics
——————————————————————
http://cancer.org/research/cancerfactsstatistics/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/index
——————————————————————
2008 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
2008 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2008/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2008/index
——————————————————————
2008 – Cancer Facts & Figures
——————————————————————

Click to access 2008cafffinalsecuredpdf.pdf

——————————————————————

Click to access 2008cafffinalsecuredpdf.pdf

——————————————————————
2008 – Cancer Facts & Figures
——————————————————————

Click to access worldcancer.pdf

——————————————————————

Click to access worldcancer.pdf

——————————————————————
Global
——————————————————————

Click to access acspc-027766.pdf

——————————————————————

Click to access acspc-027766.pdf

——————————————————————
2008 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2008/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2008/index
——————————————————————
Cancer Facts and Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
======================================
2007-2008 Breast Cancer Facts & Figures
——————————————————————

Click to access bcfffinalpdf.pdf

——————————————————————

Click to access bcfffinalpdf.pdf

——————————————————————

——————————————————————
http://komen.org/BreastCancer/BreastFactsReferences.html
——————————————————————

——————————————————————
http://ww5.komen.org/BreastCancer/BreastFactsReferences.html
——————————————————————
2007 – Cancer Facts & Figures
——————————————————————

Click to access caff2007pwsecuredpdf.pdf

——————————————————————

Click to access caff2007pwsecuredpdf.pdf

——————————————————————
2007 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2007/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2007/index
——————————————————————
2007 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2007
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2007
——————————————————————
2007-2008 Cancer Facts & Figures for African Americans
——————————————————————

Click to access caff2007aaacspdf2007pdf.pdf

——————————————————————

Click to access caff2007aaacspdf2007pdf.pdf

——————————————————————
2006-2008 Cancer Facts & Figures for Hispanics / Latinos
——————————————————————

Click to access caff2006hisppwsecuredpdf.pdf

——————————————————————

Click to access caff2006hisppwsecuredpdf.pdf

======================================
2006 – Cancer Facts & Figures
——————————————————————

Click to access caff2006pwsecuredpdf.pdf

——————————————————————

Click to access caff2006pwsecuredpdf.pdf

——————————————————————
2006 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2006
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2006
——————————————————————
2005-2006 Breast Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/breast-cancer-facts–figures-2005-2006
——————————————————————
2005-2006 Breast Cancer Facts & Figures
——————————————————————

Click to access caff2005brfacspdf2005pdf.pdf

——————————————————————

Click to access caff2005brfacspdf2005pdf.pdf

——————————————————————
2005-2006 Breast Cancer Facts & Figures
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/breastcancerfactsfigures/breast-cancer-facts–figures-2005-2006
——————————————————————
2005-2006 Cancer Facts & Figures for African Americans
——————————————————————

Click to access caff2005aacorrpwsecuredpdf.pdf

——————————————————————

Click to access caff2005aacorrpwsecuredpdf.pdf

======================================
2005 – Cancer Facts & Figures
——————————————————————

Click to access caff2005f4pwsecuredpdf.pdf

——————————————————————

Click to access caff2005f4pwsecuredpdf.pdf

——————————————————————

——————————————————————
http://worldwidebreastcancer.com/learn/breast-cancer-statistics-worldwide/
——————————————————————

——————————————————————
http://www.worldwidebreastcancer.com/learn/breast-cancer-statistics-worldwide/
——————————————————————
Cancer Facts and Figures
——————————————————————
http://cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
2005 – Cancer Facts & Figures
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2005
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2005
======================================
2003-2004 Breast Cancer Facts & Figures
——————————————————————

Click to access caff2003brfpwsecuredpdf.pdf

——————————————————————

Click to access caff2003brfpwsecuredpdf.pdf

——————————————————————
2004 – Cancer Facts & Figures
——————————————————————

Click to access CancerRates2004.pdf

======================================
2003
——————————————————————
http://cancer.org/cancer/breastcancer/detailedguide/breast-cancer-references
——————————————————————
http://m.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-references
——————————————————————
2003 – Cancer Facts & Figures
——————————————————————

Click to access 2003_ACS_Cancer_Facts.pdf

======================================
2002 – American Cancer Society Cancer Facts & Figures
——————————————————————

Click to access acspc-027766.pdf

——————————————————————

Click to access acspc-027766.pdf

——————————————————————
2002 – Cancer Facts & Figures
——————————————————————

Click to access CancerFacts&Figures2002.pdf

======================================

Advertisement

Wikipedia or Wikipediantic ? – wants your 3 pounds of flesh (WikiPEEdia, UR all INe)

[WP:SOP] “Statement of principles from Wikipedia founder Jimbo Wales, as updated by the community since then. 7.”)

Due & undue weight: [3]

“The relative prominence of each viewpoint among Wikipedia editors or the general public is not relevant & should not be considered,”

[WP:NPOV] “History of NPOV:” (Content # 6, Note 3)

(Neutral Point of View)
——————————————————————
TRANSLATION: Wikipedia editors, YOUR OPINION IS NOT RELEVANT
——————————————————————
MEANING: It is meaningless to attempt to slather your biased OPINION all over Wikipedia like butter on Texas toast, since supposedly, we only care about verifiable FACTS
======================================
Wikipedia, what the problem is ?

Jimmy Donal Wales

Who ?

No, “The Who” is actually really British !

(as opposed to some “furreigner” who plops across the pond, wants to pound one of your pelts after a celebrity hunt, pops it in his bonnet, pip-pips about, and mounts it up on his rented wall along with what’s left of his balls)

I’m writing, of course, about “Jimbo,” the one who got away . . . Thankfully

The recipient of the write-up earlier this year in The New York Times [1] (Oh, pithy !!)
——————————————————————
Wales, who no longer runs the day-to-day operations of Wikipedia

“He applies his libertarian worldview to the Internet and has taken on institutions like the United States government“
——————————————————————
You must be bloody well right joking me

(joking me ? Quit jokin’ me !)

JimCrow’s ’bout as “libertarian” as Fidel Castro with a gun in his hand and (f)lies between his teeth; from traveling with the windows down

Stephen Colbert shoulda seen that comin’ from a 8 mile away

Hey Stephen, Report’ THAT !!!
——————————————————————
“He grew up in Huntsville, Ala., the son of a teacher and a retail man“
——————————————————————
And obviously, he didn’t “learnt” well

I think a refund’s in order

And here’s your free school Insolence to go with it

Happy eat in’

It is claimed that “HE” spends time:
——————————————————————
“traveling the world giving talks on free speech and Internet freedom“
——————————————————————
seriously ?

Seriously ??

SERIOUSLY ???

Welcome to MizFitTV

What would “Jymboree” know about “free speech” and “Internet freedom,“ anyway ?

How many days did you serve your country in the United States military ?

Oh, you did NOT realize that while you were in San Diego, you could have signed that contract ?

After all, he’s no Vincent Kennedy McMahon”
(“HE” knows where “HIS” GRAPEFRUITS are)
======================================
“B.D.F.L., or the Benevolent Dictator for Life”
——————————————————————
How ’bout:

Big
Disappointing
Fascist
Loser ?
——————————————————————
“Argumentum ad Jimbonem” means dutifully following what Wales says, but there are even arguments about that”
——————————————————————
WP:NICETRY, but that’s “SHEEPLE”
——————————————————————
“One Wikipedia editor said, for instance, that Wales was no longer comfortable with the B.D.F.L. description”
——————————————————————
Jiminy Cricket !

Whazzamatta Jiminy?

Did “FASCIST” hit a bit too close to home ?
——————————————————————
“(There is, among some, a debate over what to call him)”

“Some users have also disputed the Latinized version of “Jimbo.”“

“(Should it be “Jimboni” or “Jimbini”?)”
——————————————————————
Can you smell what “The Rock” is cookin’ ?

La-La-La-La-Laaaaaaawwww, JIMBRONI !!!!!!!

Get ready, and bend over, ’cause I’m gonna shine this thing up, turn it sideways, and shove it straight up your Candy AstroTurf hatch
——————————————————————
Introduction (statement of principles) [WP:SOP]

“This is a statement of principles from Wikipedia founder Jimbo Wales, as updated by the community since then”
——————————————————————
(Or if you go by The New York Times article, [1] Jimbroni is the “co-founder” who tries to re-write history to make it appear that “HE” is the one-and-only Fascist Founder ?)
——————————————————————
“I should point out that these are my principles, such that I am the final judge of them”

“This does not mean that I will not listen to you, but it does mean that at some ultimate, fundamental level, this is how Wikipedia will be run”
——————————————————————
No, actually, it DOES mean that he will NOT listen to you, as was the case when he ignored my 2/7/2013 appeal

In his defense, perhaps Kate Garvey has his balls
——————————————————————
Principles

1. “Wikipedia’s success to date is entirely a function of our open community”

“This community will continue to live and breathe and grow only so long as those of us who participate in it continue to Do The Right Thing”

“Doing The Right Thing takes many forms, but perhaps most central is the preservation of our shared vision for the neutral point of view policy and for a culture of thoughtful, diplomatic honesty”
——————————————————————
The problem with this Wacky Tobacky “We are the (Wiki) World” WikiWhOReD Wonderland Jimbroni’s living in, is that “HE” has NOT been Doing The Right Thing since “HE” abdicated “his” “neutral point of view policy” and “culture of thoughtful, diplomatic honesty,” to “The Skeptics”

“The Skeptics,” who serve as gatekeepers of the Burzynski Clinic article, and who cite Dr. David H. Gorski a/k/a “Orac” aka GorskGeek as if he were a “reliable source”

“The Skeptics,” who bring new meaning to the term “Wikipedia Zero”

“The Skeptics,” who are Intellectual Cowards like their false god Gorski, the Closet Communist of Science-Based Medicine a/k/a Science-Basted Medicine aka Science-Based Mudicine (Spinning Bowel Movement), Wiki Wordsmith Wannabes, nut-jobbers, stale from their failure at the National Peanut Festival in Dothan, Alabama
——————————————————————
3. ““You can edit this page right now” is a core guiding check on everything that we do”

“We must respect this principle as sacred”
——————————————————————
Do the lies just dribble off your chin like phlegm?

You canNOT just go in and “edit” the Burzynski Clinic article “page right now”

That statement is pure, unadulterated Alabama B.S.

That’s NOT a “sacred principle,” it’s sacré “bull”
——————————————————————
7. “Anyone with a complaint should be treated with the utmost respect and dignity”
——————————————————————
Unfortunately, you do NOT practice what you preach, do you, HYPOCRITE ?
——————————————————————
“They should be encouraged constantly to present their problems in a constructive way”
——————————————————————
So that you can ignore the problem(s), right, Jimbroni ?
——————————————————————
“Anyone who just complains without foundation, refusing to join the discussion, should simply be rejected and ignored”
——————————————————————
THAT would automatically exclude all of “The Skeptics” now, wouldn’t it ?
——————————————————————
“We must not let the “squeaky wheel” be greased just for being a jerk”
——————————————————————
Jimbroni, why have you allowed “The Skeptics” to choose from their “squeaky” wheel-house bag o’ tricks, get all “greased” up and jerk” so many people around in such a big CIRCLE-JERK, for so long?
——————————————————————
8. “Diplomacy consists of combining honesty and politeness”

“Both are objectively valuable moral principles”

“Be honest with me, but don’t be mean to me”

“Don’t misrepresent my views for your own political ends, and I’ll treat you the same way”
——————————————————————
“Honesty” and “politeness” are really great “buzzwords,” Jimbroni, but they are as foreign to your “Skeptics,” as “moral principles”
——————————————————————
A great example of the questionable “honesty” and “moral principles” of one of your apparatchiks, was demonstrated 2/3/2013, 6:56, when I sent an arbitration appeal e-mail to Wikipedia, advising, in part, that the e-mail listed on Wikipedia; as the one that blocked users should use, did NOT work, because there was NO “@” sign in it

There was a . (period) where the “@” sign belonged
——————————————————————

——————————————————————
2/3/2013, 8:11 AM, Anthony (AGK) BASC
wikiagk@gmail.com advised:

“Everything you have said in that e-mail demonstrates a misunderstanding or misreading of Wikipedia policy”
——————————————————————

——————————————————————
Check the “time” and “place” where you are, so that you, too, can advise, that according to Wikipedia, pointing out to them that the e-mail they advise people to use, DOES NOT WORK; because there is no “@” sign in it (instead, there’s a . (period)), translates into meaning:
——————————————————————
“Everything you have said in that e-mail demonstrates a misunderstanding or misreading of Wikipedia policy”
======================================
Core principles

Wikipedia:Simplified ruleset [WP:SR]

Wikipedia does not have its own views, or determine what is “correct”
——————————————————————
I wish I could LIE like that, but I have a conscience
======================================
12/24/2012, Monday – 3:52 pm – 21:52 (UTC) –
“We are told that 2013 will be a big year, but apparently his plan is to release another bullshit movie not to publish useful research”

[User Talk:JzG|Guy] ([User JzG/help|Help!]) [2]

——————————————————————
“Bullshit movie” ?
——————————————————————

——————————————————————
Does anyone other than me NOT think it a “coinkydink” that some “Guy” on Wikipedia, going by the name “Guy”, using the same 2 words (“Bullshit movie”) as a “Guy” on Twitter ?
======================================
2. Founding principles:

“Neutrality is mandatory . . . “
——————————————————————
I call B.S.

“Neutrality is mandatory,” EXCEPT on the Burzynski Clinic article, controlled by “The Skeptics”
——————————————————————
4. “Ignore all rules (IAR):”

“Rules on Wikipedia are not fixed in stone”
——————————————————————
Especially when Jimbroni allows “The Skeptics”
to “dictator” the “rules”
——————————————————————
“The spirit of the rule trumps the letter of the rule”

“The common purpose of building an encyclopedia trumps both”

“This means that any rule can be broken for a very good reason, if it ultimately helps to improve the encyclopedia”
——————————————————————
And “The Skeptics” are NOT required to provide ANY reason for having broken “any rule”
——————————————————————
“It doesn’t mean that anything can be done just by claiming IAR, or that discussion is not necessary to explain one’s decision”
——————————————————————
But do NOT expect Wikipedia to require anything from The Skeptics”
——————————————————————
Founding principles

1. “Neutral point of view (NPOV) as a mandatory editorial principle”
—————————————————————–
EXCEPT when it comes to the Burzynski Clinic article
——————————————————————
12/26/2012 – I attempted to get Wikipedia to reference the interview which Burzynski’s attorney, Richard (Rick) A. Jaffe, and Lola Quinlan’s attorney; who posted it on his web-site, had given: [4]

Please add re WP:NPOV that Burzynski’s attorney, Richard Jaffe has disputed Lola Quinlan’s claims:

“On February 1, 2012, Dr. Burzynski’s attorney, Richard Jaffe, disputed Lola Quinlan’s allegations on Houston’s KPRC News.”

Thank you very much.[[User: Didymus Judas Thomas 15:03, 12/26/2012 (UTC)
——————————————————————
So? [OR] Disputing it in the media probably means he doesn’t have a case. [/OR] In any case, a lawyer disputing the allegations against his client is not even news. — [[User: Arthur Rubin 15:24, 12/26/2012 (UTC)

Arthur Rubin, I’m not sure what relevance your above post has re WP:NPOV since the article includes statements from attorneys representing both sides

17:51, 12/27/2012 (UTC) Didymus Judas Thomas

======================================
12/24/2012, Monday – 3:54 pm (21:54.UTC) – “What they mean is that nobody else is doing any meaningful work on it, which necessarily means that it’s not considered in the least promising.”

[[User Talk:JzG|Guy]] ([User JzG/help|Help!])

“Nobody else is doing meaningful work on it” ?

Ignores independent research done in Poland, Russia, Korea, Egypt, Japan, & China which specifically reference SRB’s publications in their publications re antineoplastons & phenylacetylglutamine (PG); which is AS2-5, & includes phase III trials published in China & continued research being published in China 12/17/2012?

FACTS:

1. I pointed out to Wikipedia, a 12/17/2012 scientific publication re antineoplastons, which referenced Burzynski @ 22. (antineoplaston AS21)

2. 7 days after this scientific journal was published, Wikipedia’a “Guy (Help!’s) ”response, Monday, 12/24/2012 @ 3:54 pm, is to advise me:

“What they mean is that nobody else is doing any meaningful work on it, which necessarily means that it’s not considered in the least promising.”

Guy (Help!) 3:54 pm, 12/24/2012, Monday

3. So, Wikipedia’s, Guy (Help!), defines an event having been published 7 days ago (12/17/2012 to 12/24/2012) as:

“…nobody else is doing any meaningful work on it…”

12/17/2012
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524164
CDA-2 (cell differentiation agent 2), a URINARY preparation
http://po.st/g71N8P
CDA-2 and its main component PHENYLACETYLGLUTAMINE (PG or PAG)
Antineoplaston AS2-5 is PHENYLACETYLGLUTAMINE (PAG or PG)
http://redd.it/1dk974
Antineoplaston AS2-1 is a 4:1 mixture of phenylacetic acid (PA) and PHENYLACETYLGLUTAMINE (PAG or PG)
Antineoplastons AS2-5 and AS2-1 are derived from Antineoplaston A10
BURZYNSKI Reference: 22.
antineoplaston AS21
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0052117
======================================
12/26/2012, Wednesday – 12:43 – “There is unlikely to be any dispassionate debate over ANPs while Burzynski continues with his unethical practices.”

JzG|Guy User:JzG/help|Help!

Wikipedia: Judge, Jury, Executioner
======================================

“The world, right now, considers Burzynski to be at best unethical and at worst a quack…”?

Since when did Wikipedia conduct a world-wide “opinion poll” re Burzynski ?

And if Wikipedia is correct, how did this happen ?

Burzynski referenced by other Cancer researchers:

2011 – Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas
http://neuro-oncology.oxfordjournals.org/content/13/3/298.full
University of California—San Francisco

Children’s Hospital Boston, Massachusetts

St Jude Children’s Research Hospital, Memphis, Tennessee

Seattle Children’s Hospital, Seattle, Washington

Children’s Hospital of Philadelphia, Pennsylvania

Children’s Hospital of Pittsburgh, Pennsylvania

Children’s National Medical Center, Washington, DC

Cincinnati Children’s Hospital Medical Center, Ohio

Neuro Oncol (2011) 13 (3): 298-306
doi: 10.1093/neuonc/noq202

5.723 Impact Factor

25. ↵ Burzynski SR
Treatments for astrocytic tumors in children: current and emerging strategies
Paediatr Drugs. 2006;8:167-178
http://link.springer.com/article/10.2165%2F00148581-200608030-00003
Pediatric Drugs
May 2006, Volume 8, Issue 3, pp 167-178
======================================

——————————————————————
Rhode Island Red attempts to get away with misquoting me:
——————————————————————

——————————————————————
“The other argument is that the secondary sources (i.e., respected cancer organizations, FDA, etc.) are not reliable because they are Burzynski’s “competitors”

[[User: Rhode Island Red]] 4:18 pm, Yesterday (UTC−6)
======================================

——————————————————————
What a Wipocrite (Wiki + Hypocrite)

Steve Pereira (SilkTork) is such a “WIPOCRITE,” that he claims:
——————————————————————
“the community were united that your contributions were biased”
——————————————————————
He conveniently; like a good little mini-Jimbroni would, ignores ALL of his fellow WIPOCRITES comments, which completely ignored:
——————————————————————
([WP:SOP] “Statement of principles from Wikipedia founder Jimbo Wales, as updated by the community since then. 7.”)

Due & undue weight: [3]

“The relative prominence of each viewpoint among Wikipedia editors or the general public is not relevant & should not be considered,”

[WP:NPOV] “History of NPOV:” (Content # 6, Note 3)

(Neutral Point of View)
——————————————————————
1. 12/24/2012, Monday – 3:52 pm – 21:52 (UTC) – “We are told that 2013 will be a big year, but apparently his plan is to release another bullshit movie not to publish useful research”
——————————————————————
2. 12/24/2012, Monday – 3:54 pm (21:54.UTC) – “What they mean is that nobody else is doing any meaningful work on it, which necessarily means that it’s not considered in the least promising.”
——————————————————————
3. 12/26/2012, Wednesday – 12:43 – “There is unlikely to be any dispassionate debate over ANPs while Burzynski continues with his unethical practices.”
——————————————————————
4. 12/30/2012 8:58 “The world, right now, considers Burzynski to be at best unethical and at worst a quack…”?
——————————————————————
Am I NOT the only one convinced that “the community” was also “united” in something more than just their “goose-stepping ?
——————————————————————
Pereira, the imperfect ‘pedia Pimp tries to Wow his readers by waxing WikiWhOReD, by ignoring that ALL the previous BIASED opinion B.S. that his fellow-Facist forged ahead with, and which Wikipediantic history says means ABSOLUTELY NOTHING (say it again) because it is their BIASED OPINION and is ABSOLUTELY WORTHLESS, and it was as so much WikiLitter, well, he’s just facist-free speechless about that, as any Jimbroni AstroTurf Twerk should be
======================================
To show exactly what zealots these WikiPimps are, just absorb this exchange:
——————————————————————
“The Burzynski Clinic Article has:

“…a Mayo Clinic study found no benefit….”

But that was not what the study concluded

See below:
——————————————————————
“CONCLUSION:

Although we could not confirm any tumor regression in patients in this study, the small sample size precludes definitive conclusions about treatment efficacy.”
——————————————————————
In the interest of Neutrality, please remove the reference to Mayo entirely or change to;
——————————————————————
“…a Mayo Clinic study found that “the small sample size precludes definitive conclusions about treatment efficacy.”
——————————————————————
Thank you very much

Didymus Judas Thomas 21:12, 12/10/2012
——————————————————————
“How is “found no benefit” not a a fair and pithy description of the Mayo Clinic study’s summary?”

Alexbrn 21:24, 12/10/2012
——————————————————————
“I feel this should be changed under WP:NPOV because not every reader is going to understand the “Fair & Pithy” reason I was provided

I feel that the average reader reading this will read it as meaning a study was done & completed with the necessary # of people for an effective study, when that was not the conclusion as pointed out in my above post

Thank you very much.”

Didymus Judas Thomas 11:02, 12/18/2012
——————————————————————
NO RESPONSE

That’s right !

“NO RESPONSE” from the “mini-b” (a/k/a “mini-brain”), wannabe Fascists who are so zealous about using their alleged “Fair and Pithy” “found no benefit” WikiWhOReD; which they utilize in an effort to deceive those who are NOT smarter than a fifth-grader

These WikiPimps are so certain of the righteousness of their evangelical cause, that they do NOT even have the “GRAPEFRUITS” to use what the study’s conclusions actually said, and let the chips fall where they may

There are a lot of “chips” falling at Wikipedia

“BULL CHIPS”

JIMBRONI, you’re no Maggie Thatcher

You can’t even wear her pants
——————————————————————
Margaret Thatcher: “The Iron Lady”

Jimbroni: “No iron in the pants”
——————————————————————
Jimbroni’s list of Facist, mini-Hitler, Monty Pythonesque Women’s underwear wearing Wannabes on Wikipediantic:

1. Alexbrn
2. fluffernutter
3. NE Ent
4. Choyoołʼįįhí:Seb az86556 (Seb az86556)
5. Tom Morris
6. Guerillero
7. Dave Dial
8. John
9. Nstrauss
10. Yobol
11. Drmies
12. foxj
13. Ironholds
14. Rhode Island Red
15. Anthony (AGK) BASC wikiagk@gmail.com
16. Steve Pereira (Silk Tork) silktork@gmail.com
——————————————————————
WikiWhOReD (Wiki + Word + Whore): Pimping a word. Attempting to deceive someone by means of misdirection with words
——————————————————————
The South will rise again, just not in Jimbroni’s pants
——————————————————————
Happy Friday the 13th, Wikipediantic
======================================
REFERENCES:
======================================
[1] – 6/27/2013 – Jimmy Wales Is Not an Internet Billionaire (By AMY CHOZICK):
——————————————————————
http://mobile.nytimes.com/2013/06/30/magazine/jimmy-wales-is-not-an-internet-billionaire.html
======================================
[2] – 12/24/2012, Monday – 3:52 pm – 21:52 (UTC) – [User Talk:JzG|Guy] ([User:JzG/help|Help!])
——————————————————————
http://en.wikipedia.org/w/index.php?title=Talk:Burzynski_Clinic&diff=next&oldid=529537854
======================================
[3] – 12/26/2012 – Lola A. Quinlan:
——————————————————————
http://en.wikipedia.org/w/index.php?title=Talk:Burzynski_Clinic&diff=prev&oldid=529836971
——————————————————————
http://en.wikipedia.org/w/index.php?title=Talk:Burzynski_Clinic&diff=next&oldid=529836971
——————————————————————
Houston’s KPRC News:
——————————————————————
http://m.click2houston.com/news/Houston-cancer-doctor-draws-new-complaints-from-patients/-/16714936/8581480/-/hmrbjk/-/index.html
——————————————————————
Lola A. Quinlan’s attorney’s web-site:
——————————————————————
http://www.jag-lawfirm.com/burzynski-suit-kprc-02012012.html
======================================
[4] – –
——————————————————————
http://en.wikipedia.org/w/index.php?title=User_talk:Didymus_Judas_Thomas&diff=next&oldid=528610760
======================================

These mini-b’s went so far as to allege all sorts of sockpuppetry

Wikipediantic, why don’t you list all the dates and times I was supposedly doing all of these activities; and don’t forget to include all the time I spent blogging, on Twitter, making comments on articles, etc., and once you have all that data compiled, explain how one individual could do all that in a 24-hour day

That’s right Wikipediantic

I’m challenging you to put up or shut up your cornholio

USA TODAY and “The Skeptics” selling false hope to cancer patients

——————————————————————
Irrespective Insolence
——————————————————————

——————————————————————
Hill ?

Sharon Hill ??

Does anyone know SHARON HILL ???
——————————————————————

——————————————————————
no ?

NoNo ??

NO NEVER MATTER
——————————————————————

——————————————————————
NOT HARDLY !

If it’s “Doubtful News”, that’s a “Hint and a Half” that it’s “Doubtful” it’s “News” [1]

In fact, I first received confirmation that what flows down-Hill was definitely, NO doubtfully, NOT news, when she displayed her “propensity” for “density” on #Forbes [2]
——————————————————————

——————————————————————
“Orac”, “The Skeptics™” Dope-on-a-Rope Pope. claimed:

4/19/2013 – “also obsessively read anything posted about Eric Merola or Stanislaw Burzynski on any social media.”
——————————————————————

——————————————————————
5/7/2013 – “If “Orac” was anywhere close to being 75% sure, I would have already reviewed “Doubtful News,” which received “free pub” on Forbes
——————————————————————

——————————————————————
“The Skeptics™” must have got into Liz Szabo’s ear, since she subsequently short-sheeted herself by being unable to answer her own question
——————————————————————

——————————————————————
Maybe Szabo shoulda asked the F.D.A. !!
——————————————————————

——————————————————————
All that Jerry Mosemak (@jmosemak), Connie Mosemak, and Mosemak Creative (@mosemakcreative) wanted to know was what Twitter thought of their Twerk
——————————————————————

——————————————————————
Bob Blaskiewicz, fresh off the AstroTurf campaign with “Orac’s” orifice, seemed ready to really be headed, right in to rectify on Liz’s
——————————————————————

——————————————————————
Liz, do you really want this anywhere around your backside ?
——————————————————————

——————————————————————
Bob-B obviously confused Liz Szabo with being a “journalist“, when she is a “reporter“

Ms. Szabo, is obviously NOT a “journalist”
——————————————————————
Liz Szabo (USA TODAY) – health reporter, medical reporter covering cancer, heart disease, pediatrics, public health, women’s health, kids/parenting, …
——————————————————————
The question is, how did a “reporter” like Liz Szabo, manage to get her name as the reporter “headlining” “The Skeptics™” “report,” instead of Robert Hanashiro ?

Hanashiro had under his belt:
——————————————————————
8/3/2011 – Urine test may help predict prostate cancer risk [4]
——————————————————————
The best Szabo could cite as support was:
——————————————————————
3/19/2008 – “Prostate cancer treatments’ sexual, urinary side effects compared” [5]
——————————————————————
Exactly how did Liz Szabo “win” that “pissing contest” ?

Even a monkey can report the news:

10/18/2013 – Monkeys ‘talk in turns’ [6]

If @LizSzabo wanted to do a REAL article on “selling false hope to cancer patients”, then USA TODAY should have done an “investigation” on something like THIS:
======================================
8/25/2010, Wednesday [7]
——————————————————————
Canadian Man Sentenced to 33 Months (2 years 9 months) in Prison for Selling Counterfeit Cancer Drugs Using the Internet

Hazim Gaber, 22, of Edmonton, Alberta, Canada sentenced in Phoenix, Arizona by U.S. District Court Judge James A. Teilborg

Ordered to pay $128,724 ($75,000 fine $53,724 in restitution)

Serve 3 years of supervised release following prison term for selling counterfeit cancer drugs using Internet
——————————————————————
6/30/2009 – indicted by federal grand jury in Phoenix, Arizona: 5 counts of wire fraud for selling counterfeit cancer drugs through website DCAdvice.com
——————————————————————
7/25/2009 – arrested Frankfurt, Germany
——————————————————————
12/18/2009 – extradited to United States
——————————————————————
5/2010 – plea hearing: admitted selling what he falsely claimed was experimental cancer drug sodium dichloroacetate, also known as DCA, to at least 65 victims (.10/2007 – 11/2007) in:
1. United States
2. Canada
3. United Kingdom
4. Belgium
5. the Netherlands

According to plea agreement, charged:
$23.68 for 10 grams of purported DCA
$45.52 for 20 grams
or
$110.27 for 100 grams
plus shipping

Admitted sent victims white powdery substance later determined through laboratory tests to contain:
1. dextrin
2. dextrose
3. lactose
4. starch
Contained no DCA

According to court documents, along with counterfeit DCA, packages also contained fraudulent certificate of analysis from fictitious laboratory and instructions on how dilute and ingest bogus DCA

DCA is experimental cancer drug not yet approved by U.S. Food and Drug Administration for use in United States

According to plea agreement knew that website DCAdvice.com contained false claims it was only legal supplier of DCA and falsely claimed it was associated with University of Alberta

According to information contained in plea agreement, DCA is odorless, colorless, inexpensive, relatively non-toxic experimental cancer drug highly sought by cancer patients

Doctor at University of Alberta in Canada published report in early 2007 summarizing results of study, which showed DCA caused regression in several cancers, including:
1. breast cancer
2. cancerous brain tumors
3. lung cancer

According to information contained in plea agreement, DCA cannot be prescribed by medical doctor in:
1. United States
or
2. Canada
since:
1. it is not approved for use in patients with cancer
2. nor is DCA available in pharmacies

As part of plea agreement, agreed to:
1. forfeit
or
2. cancel
any:
1. website
2. domain name
3. Internet services account
related to fraud scheme

“Hazim Gaber went from selling false hope to cancer patients to now spending 33 months in a U.S. prison,”

said Assistant Attorney General Lanny A. Breuer of Criminal Division

“Criminals often seek to exploit the most vulnerable of victims – but offering fake, unapproved medication to cancer patients reaches a new low”

“Today’s sentence shows that cyber criminals who prey on the seriously ill cannot elude justice simply by committing crimes outside of our borders.”

“Gaber used the Internet to victimize people already suffering from the effects of cancer,”

said Dennis K. Burke, U.S. Attorney for District of Arizona

“Now he will go to prison for this bogus business and heartless fraud.”

“The FBI and the U.S. Attorney’s Office are committed to pursuing individuals who prey on those who are living with the affects of cancer,”

said Nathan Gray, Special Agent in Charge of FBI Phoenix Division

“Today’s sentencing illustrates international law enforcement partners working together to send a message not to use the Internet to perpetuate fraud, especially against those afflicted with a serious medical condition.”

Sentencing part of larger department-wide effort led by Department of Justice Task Force on Intellectual Property (IP Task Force)

Attorney General Eric Holder created IP Task Force to combat growing number of:
1. domestic
2. international
3. intellectual property crimes
protect:
1. health
2. safety
of American consumers
safeguard nation’s economic security against those who seek to profit illegally from American creativity, innovation and hard work

IP Task Force seeks to strengthen intellectual property rights protection through heightened:
1. civil enforcement
2. criminal enforcement
greater coordination among:
1. federal
2. state
3. local
law enforcement partners
increased focus on international enforcement efforts, including reinforcing relationships with key:
1. foreign partners
2. U.S. industry leaders

To learn more about IP Task Force, go to http://www.justice.gov/dag/iptaskforce/

Announced:
1. Assistant Attorney General Lanny A. Breuer of Criminal Division
2. U.S. Attorney Dennis Burke for District of Arizona
3. FBI Special Agent in Charge of Phoenix Field Office Nathan T. Gray

Case prosecuted by:
1. Trial Attorney Thomas S. Dougherty of Criminal Division’s Computer Crime and Intellectual Property Section
2. Assistant U.S. Attorney Peter Sexton of U.S. Attorney’s Office for District of Arizona

Significant assistance provided by:
1. Alberta Justice Office of Special Prosecutions-Edmonton
2. Alberta Partnership Against Cross Border Fraud
3. Competition Bureau of Canada
4. Edmonton Police Service
5. Federal Trade Commission
6. U.S. Postal Inspection Service

Criminal Division’s Office of International Affairs provided assistance in case

Case investigated by Phoenix FBI Cyber Squad
10-958 Criminal Division
======================================
7/30/2013 – United States to Settle Cancer Research Grant Fraud [8]
——————————————————————
Northwestern University to Pay Nearly $3 Million to United States to Settle Cancer Research Grant Fraud Claims

$2.93 million – Northwestern University will pay United States to settle claims of cancer research grant fraud by former researcher and physician at university’s Robert H. Lurie Comprehensive Center for Cancer in Chicago

Agreed to settlement in federal False Claims Act lawsuit after government investigated claims made by former employee and whistleblower who will receive portion of settlement

Alledgedly allowed researcher, Dr. Charles L. Bennett, to submit false claims under research grants from National Institutes of Health

Settlement covers improper claims Dr. Bennett submitted for reimbursement from federal grants (1/1/2003 – 8/31/2010) for:
1. food
2. hotels
3. travel
4. other expenses
5. professional and consulting services
6. subcontracts
that benefited:
1. Dr. Bennett
2. family
3. friends

Allegations made in civil lawsuit filed under seal 2009 by Melissa Theis, (2007 and 2008) worked as purchasing coordinator in hematology and oncology at Northwestern’s Feinberg School of Medicine, will receive $498,100 in settlement proceeds

Suit named defendants:
1. Dr. Bennett
2. Dr. Steven T. Rosen
3. Lurie Cancer Center
4. Northwestern

Alleged defendants submitted false claims to United States when:
1. Dr. Bennett
2. Dr. Rosen
directed and authorized spending of grant funds on goods and services that did not meet applicable NIH and government grant guidelines

Government contends has certain civil claims against Northwestern arising out of Northwestern’s improper submission of claims to NIH for grant expenditures for items that were for personal benefit of:
1. Dr. Bennett
2. family
3. friends
incurred in connection with grants as to which he was principal investigator

Northwestern, fully cooperated during investigation, did not admit liability as part of settlement

Agreement releases university and all its affiliates and employees, other than Dr. Bennett, from claims made in whistleblower lawsuit

Northwestern agreed to pay settlement within 14 business days

Agreement covers allegations university submitted false claims to NIH for costs Dr. Bennett incurred on grant-funded research projects involving:
1. adverse drug-events
2. blood disorder known as thrombotic thrombocytopenic purpura
3. multiple myeloma drugs
4. quality of care for cancer patients

Dr. Bennett allegedly billed federal grants for:
1. family trips
2. meals
3. hotels
for
1. himself
2. friends
and “consulting fees” for unqualified:
1. friends
2. family members
including:
1. brother
2. cousin

At Dr. Bennett’s request, Northwestern allegedly improperly subcontracted with various universities for services that were paid for by NIH grants

Allegations investigated by:
1. Federal Bureau of Investigation
2. National Institutes of Health
3. U.S. Attorney’s Office
4. U.S. Department of Health and Human Services Office of Inspector General

“Allowing researchers to use federal grant money to pay for personal travel, hotels, and meals, and to hire unqualified friends and relatives as ‘consultants’ violates the public’s trust,”

said Gary S. Shapiro, United States Attorney for Northern District of Illinois

“This settlement, combined with the willingness of insiders to report fraud, should help deter such misconduct, but when it doesn’t, federal grant recipients who allow the system to be manipulated should know that we will aggressively pursue all available legal remedies,”

he added

“The mismanagement or improper expenditure of grant funds is unacceptable and will not be tolerated,”

said Lamont Pugh III, Special Agent-in-Charge of U.S. Department of Health and Human Services, Office of Inspector General – Chicago Region

“The OIG will continue to diligently investigate allegations of this nature to ensure that taxpayer dollars are being properly utilized.”

Cory B. Nelson, Special Agent-in-Charge of Chicago Office of Federal Bureau of Investigation said:

“The FBI takes allegations of fraud seriously, especially those allegations from insiders who are often in the best position to detect wrongdoing long before it would otherwise come to the attention of law enforcement.”

United States represented by:
Assistant U.S. Attorney Kurt N. Lindland

Under federal False Claims Act, defendants may be liable for triple amount of actual damages and civil penalties between $5,500 and $11,000 for each violation

Individual whistleblowers may be eligible to receive between 15 and 30 percent of amount of any recovery
======================================
Show EmorME the Money ! [9]
——————————————————————
8/28/2013, Wednesday

$1.5 Million – Emory University False Claims Act Investigation

University Overbilled Medicare and Medicaid for Patients Enrolled in Clinical Trial Research at Emory’s Winship Cancer Institute

Settlement with Emory University

$1.5 million – agreed to pay to settle claims it violated False Claims Act by billing:
1. Medicaid
2. Medicare
for clinical trial services not permitted by:
1. Medicaid rules
2. Medicare rules

Providers generally not permitted to bill Medicare for medical care and services for which clinical trial sponsor agreed to pay

1. United States
2. State of Georgia
alleged Emory University billed:
1. Medicaid
2. Medicare
for services clinical trial sponsor agreed to pay

(and, in some cases, actually did pay, thereby resulting in Emory’s being paid twice for the same service)

Investigation of Emory University revealed institution’s clinical trial false billing and led to settlement

Civil settlement resolves lawsuit filed by Elizabeth Elliot under qui tam, whistleblower, provisions of False Claims Act

Ms. Elliot will receive share of settlement payment that resolves qui tam suit

United States Attorney’s Office for Northern District of Georgia
Attorney General Sam Olens announced reached settlement

“This settlement demonstrates our office’s continued commitment to protect crucial Medicare and Medicaid dollars,”

said United States Attorney Sally Quillian Yates

“Treatment of cancer is expensive, and Medicare and Medicaid dollars should be reserved for patients who need services that properly may be billed to these programs.”

“Our investigation of Emory University revealed the institution’s clinical trial false billing and led to today’s settlement,”

said Derrick L. Jackson, Special Agent in Charge of U.S. Department of Health and Human Services, Office of Inspector General for Atlanta region

“Protecting Medicare — and taxpayer dollars — remains a top priority.”

Mark F. Giuliano, Special Agent in Charge, FBI Atlanta Field Office, stated:

“Federal funds, to include those of Medicare and Medicaid, are limited and are to be used as intended”

“The FBI will continue to play a role in enforcing federal law that governs the use of these much needed funds.”

Attorney General Sam Olens stated,

“Cancer research is paramount to saving and extending lives”

“However, strict rules govern the use of Georgia Medicaid dollars”

“My office takes seriously its obligation to ensure that these resources are used properly.”

Case investigated by:
1. Federal Bureau of Investigation
2. Georgia Medicaid Fraud Control Unit
3. United States Attorney’s Office for Northern District of Georgia
4. U.S. Department of Health & Human Services, Office of Inspector General

Civil settlement reached by Assistant United States Attorney Darcy F. Coty

For further information please contact U.S. Attorney’s Public Affairs Office at USAGAN.PressEmails@usdoj.gov

Internet address for HomePage for U.S. Attorney’s Office for Northern District of Georgia
http://www.justice.gov/usao/gan.
Emory Settlement Agreement
======================================
5/24/1993 – Court Testimony Of Nicholas Patronas, MD:
——————————————————————
Pg. 122
——————————————————————
“We have done– we have an experimental protocol at the NIH where we inject a chemotherapeutic agent through the carotid artery, the artery that goes to the brain, and we have three survivals with this technique, by providing massive amounts of chemotherapeutic drugs to the brain that harbors the tumor“

“And we destroy the tumor, but we destroy a large part of the brain as well, and the patients became severely handicapped, and a life that’s not worth living“
——————————————————————
Pg. 123
——————————————————————
“And so I have three cases with this particular experimental protocol which resulted in killing the tumor, but a large part of the healthy brain as well“

“So overall the protocol was abandoned and is not any more in effect because of the serious side effects that we witnessed”
——————————————————————
Nicholas J. Patronas
National Institutes of Health (NIH)
http://www.cc.nih.gov/drd/staff/nicholas_patronas.html
——————————————————————
Sharon Hill, you’re just a footnote to this article, because all you did was “cut-and-paste”, and try to pass off David H. Gorski, M.D., Ph.D., FACS and Bob Blaskiewicz as “reliable sources”

You’ve gotta be kidding me !!!
——————————————————————
P.S. A fifth-grader can “cut-and-paste”

Are you smarter than a 5th-grader ?
======================================
REFERENCES:
======================================
[1] – 11/15/2013 – Burzynski exposed in USA Today:
——————————————————————
http://doubtfulnews.com/2013/11/burzynski-exposed-in-usa-today/
======================================
[2] – 5/6/2013 – Critiquing “The Skeptic” Burzynski Critics: A Film Producer, A Cancer Doctor, And Their Critics (page 10):
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/05/06/critiquing-the-skeptic-burzynski-critics-a-film-producer-a-cancer-doctor-and-their-critics-page-10/
======================================
[3] – 5/7/2013 – Critiquing: Is Eric Merola issuing bogus DMCA takedown notices against critics of Stanislaw Burzynski?:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/05/07/critiquing-is-eric-merola-issuing-bogus-dmca-takedown-notices-against-critics-of-stanislaw-burzynski/
======================================
[4] – 8/3/2011 – Urine test may help predict prostate cancer risk:
——————————————————————
http://usatoday30.usatoday.com/news/health/medical/health/medical/cancer/story/2011/08/Urine-test-may-help-predict-prostate-cancer-risk/49790014/1?fullsite=true
——————————————————————
http://www.usatoday.com/news/health/medical/health/medical/cancer/story/2011/08/Urine-test-may-help-predict-prostate-cancer-risk/49790014/1
======================================
[5] – 3/19/2008 – “Prostate cancer treatments’ sexual, urinary side effects compared”:
——————————————————————
http://usatoday30.usatoday.com/news/health/2008-03-19-prostate-cancer_N.htm
======================================
[6] – 10/18/2013 – Monkeys ‘talk in turns’:
——————————————————————
http://www.bbc.co.uk/worldservice/learningenglish/language/wordsinthenews/2013/10/131018_witn_monkeys.shtml
======================================
[7] – 8/2010
——————————————————————
http://www.justice.gov/opa/pr/2010/August/10-crm-958.html
======================================
[8] – 7/30/2013
——————————————————————

http://www.justice.gov/usao/iln/pr/chicago/2013/pr0730_01.html
======================================
[9] – 8/28/2013 – Emory University
——————————————————————
http://www.justice.gov/usao/gan/press/2013/08-28-13b.html
======================================
[10] – 5/24/1993
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/09/25/5241993-court-testimony-of-nicholas-petronas-md/
======================================

Shock and hee-hAW on scienceblogs . com/Insolence

——————————————————————
Gumby giveth, and Gumby sayeth away
——————————————————————
The Spinning Bowel Movement (SBM) masticulation which emanates from the breadth and width of the National Geographic (#NatGeo) Geeosphere of Respectful IsNoSense, is such, it requires that “words be combined” and “new words be created” in order to elucidate the effluence running through the collective soul of the Vulcan MindMeldLess masses
======================================
#31 – Narad – 11/16/2013 [1]
——————————————————————
“Best accidental tipoff I’ve noticed from the Scamway PR machine, courtesy Josephine Jones (PDF):”
——————————————————————
“Once your treatment plan has been fulfilled, you will be discharged from the clinic and will return home to continue treatment with the assistance of your local physician(s)”

“This rather clearly does not mean “by us.”
——————————————————————

Click to access burzynskiclinicinfo-cr.pdf

——————————————————————
Nary
a
rational
answer
deducible

Narad, the Hero of the Zeroes, acks as if some great mystery has just been unmasked before the unmindful crevmasses

A hole in the head,
A hole in the head,
When he’s reincarnated,
He wants his name to be Zeb

We, the sheeple

What ?

Wyatt ?

We are familsheep
======================================
#29 – The Very Reverend Battleaxe of Knowledge – 11/18/2013 [2]
——————————————————————
“Has anybody been monitoring DJT?”

“Has he gotten Medieval on USA Today’s ass yet?”
——————————————————————
SeriouExcuseMe, but if you chose “The Very Reverend Battleaxe of Knowledge” as your pseudonym, and this was the bestion you could acks, you must not be the “sharpest” Tool hacking at the “tree of stupendity

You’re no Right Rev’rend Leviticus Fall, well
——————————————————————
#30 – Lawrence – 11/18/2013
——————————————————————
“@TVRBA – oh, I guess I’ve made him angry…..lol….”
——————————————————————
Hardly, NoBardly [3]

If USA TODAY needed a Troll to take up a 3rd of the Facebook comments on Liz Szabo’s fabled fish tale, you were the perfect “Mark McAndrew is Trollolo” [4] to Trollolo all over there, as none of “The Skeptics™” probably would have come within a 10-foot pole of touching your nonSeance, when you intimated that you “talked to the dead”, and they chose you, of all sheeple, to

Look at the church,
See the steeple ?
Open the doors,
See all “The Skeptics™” sheeple ?
——————————————————————
#33 – Narad – 11/18/2013
——————————————————————
“oh, I guess I’ve made him angry…..lol….”
——————————————————————
“I seem to be missing the part where he demonstrates the 18 CENSORED COMMENTS bit, but at least there’s the consolation of the deranged meltdown itself”

““I’ll show them!!!”

“I’ll POST DOZENS OF PICTURES OF MY PHONE FOR NO APPARENT REASON!!!”

“AAAHAHAHAHAHA!!!!””
——————————————————————
The biggest gap in genius on GorskiGeek’s blogs, is that there is no “I” in genus, ever since GorskGeek gaffed by going Gabroni gambit

Why NearDoWell seems “to be missing the part where he demonstrates the 18 CENSORED COMMENTS bit”, is because grasping the concept of selecting (clicking on) a link, is something nonnative to Narad’s knowledge
[5]

Not
a
really
astute
display
of Science-Based Medicine

I did NOT “post dozens of pictures OF MY PHONE“

However, I DID post dozens of pictures of your dunderheaded display of dummkopfedness
——————————————————————
#35 – Lawrence – 11/18/2013
——————————————————————
“@Narad – I didn’t realize I quoted quite so well…..double the pleasure, double the fun!”
——————————————————————
In your defense, I daresay the difference is definitely:

Double the Dumb
——————————————————————
#12 – AntipodeanChic – 11/22/2013
——————————————————————
“I have to wonder now whether my liver is missing a peptide or two…”

“Slightly OT for this thread, but the other day I was finally able to make myself watch “Hannah’s Anecdote”“

“I presume I’m not the only one who shuddered at the cavalier back-room insertion of her Hickman catheter”

“I’m afraid I couldn’t really discern any adequate sterile field & I have NEVER heard of these kinds of lines being inserted while the patient is only mildly sedated“

“I’m surprised sepsis doesn’t take out more of Dr. B’s patients than the toxicity does”
——————————————————————
It’s not your liver you should be concerned about

I’m surprised stupendity doesn’t take out more of Dr. G’s pundits than the errors do [6]

One would have hoped that AntiPoorSceneCheck would have been be able to get away from the popcorn and Science-Biased Mudicine, but instead, if she ever saw a “fact”, she did NOT do the double-check Chic
——————————————————————
Day Three (7:44)
——————————————————————
“Yeah
Inject sugar and then you’re also having a, this Hickman line fitted”

“Yeah”

“Yeah”
——————————————————————
Day Three (9:28)
——————————————————————
“Right”
“So uh were just getting ready now for Hannah to go in and have her PET scan and uh catheter Hickman line fitted and she’s just filling in the form”
——————————————————————
Day Three (9:48)
——————————————————————
(?)

(laughing) “You’ve just taken some , some Valium as well, have you ?”

“Not helping”
——————————————————————
12/13/2011 – Day 3 – Tuesday
Burzynski Clinic

Valium

(as much local anesthetic as could give her w/o knocking her out)

catheter – Hickman line

(painful / really painful)
——————————————————————
Day Three (10:04)
——————————————————————
“What I’m doing is I’m creating a little tunnel under the skin
So I have to use just a little bit of pressure
So if I hurt you, you tell me
Ok” ?

“How are you feeling” ?

“Shhh”

(laugh)
——————————————————————
Day Three (10:30)
——————————————————————
“Did, did, did you feel that when it was going in and stuff” ?

“Not really”

“Little bit
It’s a little bit painful now” ?

“Yeah
It’s quite really painful now
Yeah”
——————————————————————
Day Four (10:52)
——————————————————————
“I’m feeling wrecked, absolutely wrecked”

(laugh)
“Well you had, bit of Valium yesterday”

“Yeah”

“And you had as much um local anesthetic”

“Yep”

“as he could give you he said, without knocking you out”

“Yeah”
——————————————————————
Day Four (11:23)
——————————————————————
#31 – Stupendous Stupendity Stupifies Scienceblogs . com/Insolence | Didymus Judas Thomas’ Hipocritical Oath Blog
November 25, 2013
[…] http://scienceblogs.com/insolence/2013/11/22/is-anyone-attending-the-4th-quadrennial-meeting-of-the-&#8230; […]
——————————————————————
#32 – eNOS – holed up in the lab for Thanksgiving – 11/25/2013
——————————————————————
“OT..sort of, but I was feeling particularly self-flagellating this afternoon so I clicked the DJT linkout (or whatever its called) at #31″

“Wow”

“Either I can’t find whatever point it’s making, or that’s just timecube-level crazy”

“Carry on”
—————————————————————–
This should NOT come as any surprise, as eNOS is NO Val Venus

eNOS probably can NOT even figure out where Robert J. (don’t call me “Bobby”) Bob (I’m NOT a doctor, I just play like I’m one on The Other Burzynski Patient Group (TOBPG)) Blaskiewicz Blatherskitewicz, is, and I’ve known for quite some time now that Bob has his head so far up Dr. David H. Gorski a/k/a “Orac” a/k/a GorskGeek’s ASStroturf campaign, that he should be the spokesmodel for “The Chocolate Thunder from Down Under”
——————————————————————
#33 –Lawrence – 11/25/2013
——————————————————————
“@eNOS – I don’t believe there is a rational bone in that guy’s body…he posts up a link here, just to try to drive “curiosity-seekers” to his blog…..incoherent doesn’t even begin to describe him”
——————————————————————
Lawrench threw a monkey when GorskiGeek had to edumacate him that I do NOT post “up a link” to “Orac’sl HACK attack QUACK check-my-facts it’s just WHACK
——————————————————————
#34– palindrom – 11/25/2013
——————————————————————
“Lawrence @33 — Crank.net uses the wonderful category “illucid” for some of its crankier entries”

“This adjective is all too useful these days”
——————————————————————
#35 – Lawrence – 11/25/2013
——————————————————————
“@Palindrom – yes, a very good term….hey, at least I got an honorable mention over at insano’s site…kind of funny, actually”
——————————————————————
#36 – eNOS – 11/25/2013
——————————————————————
“I was unaware of the existence of crank.net”

“This is just wonderful and along the lines of tvtropes for a good afternoon of time wasting or entertainment between western blot transfers”

“Thank you!”
——————————————————————
What the 3 Amigob-smackers should do is grow a pair and stop bowing down to the Hitler of Histrionics, the Lenin of Lip-service, the Mussolini of MisDisInformation, the Pol Pot of Pusillanimousness, the Stalin of Stupendity
——————————————————————
#37 – Eric Lund – 11/25/2013
——————————————————————
“eNOS@32:”

“I infer from the domain name that this dude is pro-Burzynski (or at least thinks he is), but have never followed his trackback links to find out”

“(Presumably Rajmund is Dr. B’s middle name–that would be the Polish equivalent of Raymond.)”

“He went for alliteration in this post title, but I have no idea what “stupendous stupendity” (sic, from our Department of Redundancy Department) is supposed to mean”

“I’ll take your word for it that the post would not enlighten me on this point”
——————————————————————
I infer from your duh-same, that you’re insane in the membrane with an L.A. in S.B.M.

You can’t fix stoopid
——————————————————————
#39 – Krebiozen – 11/25/2013
——————————————————————
“DJT stomped about the scepticsphere for several months, including a sojourn here, insulting anyone who criticized Burzynski”

“He had multiple accounts banned on Twitter and has mostly retreated back to the almost comment-free blog he created”

“He did apparently debate Bob Blaskiewicz about Burzynski somewhere, but I haven’t expended much energy finding the transcript, as DJT is just too far gone for it to be interesting”

“I’m a bit concerned for his mental health, sincerely”

“Does anyone have any idea what the photo at the top of his blog represents”?

“It looks like a gloved hand wiping away a drop of urine, but I could be mistaken”
——————————————————————
Your S.B.M. “ranks” right up there

I NEVER had a “debate” with Bob, because he is a SkeptiCoward© dissimulator who does NOT understand the term “debate”
——————————————————————
#40 – Narad – 11/25/2013
——————————————————————
“Does anyone have any idea what the photo at the top of his blog represents”?

“It looks like a gloved hand wiping away a drop of urine, but I could be mistaken”

“It appears to be a cropped image of Gumby“

“Don’t ask me”
——————————————————————
Unfortunately, you’ve NEVER exhibited the “stones” based mastery necessary to sod off on “Orac,” piss-boy

Sha-mone

You know it
——————————————————————
#41 – eNOS – 11/26/2013
——————————————————————
“@Eric”

“There isn’t much of a post to speak of, as it goes”

“It’s mostly a smattering of links to other blog posts, miscellaneous things in brackets and bolded , and my god would you look at the tags”

“Those alone had to take up half the afternoon”

“The exchange with Bob would be entertaining, although I don’t know if I could parse DJT’s comments, given his “interesting” online vernacular”

“The photo on top is indeed gumby, turned on his side it looks like”

“The full picture appears as the thumbnail on a tab if you have the blog opened in firefox (probably chrome as well)”
——————————————————————
I just bet that down at the ol’ precinct house, they call you “no-shit Sherlock” !
——————————————————————
#42 – Orac – 11/26/2013
——————————————————————
“DJT amuses me”

“It’s the only reason I let his Trackbacks through”
——————————————————————
Poor Sad “OrSac” amuses me

I envision him in a “Hearing” with “Hey” Joe

Communist, yes ?

“I’m not a communist, Senator”

“You look like a communist”

“I am not one of them, Senator McCarthy”

“You even smell like a commie”

Senator, the court even stated, and I quote: GorskGeek is “not ordinary communist”

I don’t care what your flamin” court called you, by gawd”

“You’re a commie, so why don’t you just grab your commie pinko blahg, Guy Chapman, and go ‘talk to the hand,’ up there by Lake Superior, while you commimune with nature, commie” !!

“Damn communists” !!!

“Next thing ya know, they’ll be wanting to ‘tie one on’“
——————————————————————
#43 – Lawrence – 11/26/2013
——————————————————————
“@Orac – I glance at his page from time to time…still incoherent….though getting a mention from him (well, pissing him off, actually) did give me quite the thrill….lol”
——————————————————————
Lawrry, the only thing you’ve been “pissing off” is the floor, again, because your scatterillogically bound missive, missed again
——————————————————————
#44 – Narad – 11/26/2013
——————————————————————
“The photo on top is indeed gumby, turned on his side it looks like”

“When I was looking at this last night, it seemed as though, based on where the drops of moisture appear on the thunbnail (which does not appear anywhere when I view the page in Firefox), it was probably Gumby’s right hand, cropped with the image upside-down”

“Then again, I’m little inclined to check again”

“I’m mildly amused by all the dot-anchored links at the top that are password-protected”

“Because, you know, if I want to organize files, I always put the cabinet out on the sidewalk with a sign on it saying “IMPROTNT FLIES” and then safeguard the key”
——————————————————————
“The Skeptics™” “conspiracy theorists” like Red Herring so much

Who am I to deny them ?
——————————————————————
#45 – Krebiozen – 11/26/2013
——————————————————————
“Does anyone have any idea who DJT is” ?

“I don’t mean a name, I don’t want to out him, but I wonder whether he is associated with Burzynski in any way, if he has had a relative ‘cured’ by Burzynski, or if is he is just a concerned citizen, as it were”

“Whoever he is, he seems to have put a gargantuan effort into producing an enormous amount of evidence that he has a somewhat tenuous grip on reality”

“Gumby indeed”

“Truly bizarre”
——————————————————————
Kreblogizen, everyone knows what you have a “grip on”, and it’s assuredly NOT “reality”
——————————————————————
#46 – AdamG – 11/26/2013
——————————————————————
“Does anyone have any idea who DJT is”?

“Orac knows…I’m pretty sure I remember him saying he had a pretty good idea, at least”
——————————————————————
But then again, “Orac’s” been trying to convince his wife for years; without any luck, that he’s “about 75% sure” he “knows” where the “pisser” is
——————————————————————
#47 – AntipodeanChic – Apparently, the Land of “Asinine & Stupendous Stupidity (Pop. 1)” – 11/26/2013
——————————————————————
“Oh dear!”

“There I was, on tenterhooks overnight, fearing that I may have brought Respectful Insolence into some kind of dreadful disrepute”.*

“Granted, I had tried to make a weak joke about Suzanne Somers’ handing out medical advice – but I cannot fathom why pointing out an instance of dodgy clinical protocol should earn one an entire blog post, particularly as nobody else on the thread even responded to it”

“Clearly, my stupidity & lack of experience in that particular field must be to blame”.**

“Now, I had intended to avoid providing more fodder for my new friend but I agree with Krebiozen – I have to wonder at his motivation(s)”?

*Sarcasm

**Searing sarcasm tinged w/ bemusement
——————————————————————
Yep

hee-hAW, population “one”
——————————————————————
#48 – eNOS – 11/27/2013
——————————————————————
“This may come through twice, as the first was given a “you’re posting comments to quickly” error”

“I didn’t even realize those dots on the top were links”

“Odd”

“I do wonder what he thinks he’s accomplishing with his rhetoric”

“The only thing I can really make out is that he is a Burzynski supporter, as Kreb mentioned above, but surely he can’t believe anyone on the same side considers him a legitimate ally when he posts all that mess”

“I will note that the about section is a bit more readable”

“I wonder if all this talk will open the gates for him here”

“Are he and his various iterations banned”?

“I forget”

“Oh, and Narad, this is the tiny Gumby thumbnail I referenced that appears in Firefox:”
——————————————————————
But then again, you can reference no other “Burzynski supporter,” who cites a case that went against him

entirely
Nonsensical
On
Science

“Odd”

Singular-Bowel Movement (S.B.M.)
======================================
REFERENCES:
======================================
[1] – 11/15/2013 – Stanislaw Burzynski in USA Today: Abuse of clinical trials and patients versus the ineffectiveness of the FDA and Texas Medical Board
——————————————————————
http://scienceblogs.com/insolence/2013/11/15/stanislaw-burzynski-in-usa-today-abuse-of-clinical-trials-and-patients-versus-the-ineffectiveness-of-the-fda-and-texas-medical-board/
======================================
[2] – 11/18/2013 – Eric Merola and Stanislaw Burzynski respond to the FDA findings and the USA TODAY story. Hilarity ensues:
——————————————————————
http://scienceblogs.com/insolence/2013/11/18/eric-merola-and-stanislaw-burzynski-respond-to-the-fda-findings-and-the-usa-today-story-hilarity-ensues/
======================================
[3] – 11/18/2013 – USA TODAY CENSORS 18 comments of Military Veteran who Protected Their “Right to Free Speech” (They post 119 comments of “The Skeptics™” Troll, Lawrence McNamara) BIAS, CENSORED, CENSORING, CENSORSHIP by BIASED CENSOR:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/11/18/usa-today-nation-censor-censors-censored-censoring-censorship-bias-biased/
======================================
[4] – 10/25/2013 –
“The Skeptics™” Mark McAndrew is Trollolo:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/10/25/the-skeptics-mark-mcandrew-is-trollolo/
======================================
[5] – 11/16/2013 – Critiquing: Doctor accused of selling false hope to families (USA TODAY NEWS, NATION, Liz Szabo, USA TODAY):
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/11/16/httpwww-usatoday-comstorynewsnation20131115stanislaw-burzynski-cancer-controversy2994561/
======================================
[6] – 11/25/2013 – Stupendous Stupendity Stupifies Scienceblogs . com/Insolence:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/11/25/stupendous-stupendity-stupifies-scienceblogs-cominsolence/
======================================
[7] – 10/25/2013 – Hannah Bradley – I Feel Empowered, In Control Of My Body: Four Women On Fighting Cancer With Alternative Therapies http://www.telegraph.co.uk/health/10383724/I-feel-empowered-in-control-of-my-body-four-women-on-fighting-cancer-with-alternative-therapies.html
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/10/25/hannah-bradley-i-feel-empowered-in-control-of-my-body-four-women-on-fighting-cancer-with-alternative-therapies-httpwww-telegraph-co-ukhealth10383724i-feel-empowered-in-control-of-my-body-fo/
======================================
11/22/2013 – Is anyone attending the 4th Quadrennial Meeting of the Society of Neuro-Oncology in San Francisco right now?:
——————————————————————
http://scienceblogs.com/insolence/2013/11/22/is-anyone-attending-the-4th-quadrennial-meeting-of-the-society-of-neuro-oncology-in-san-francisco-right-now/
======================================

All’s fair in Drugs and War

======================================
GlaxoSmithKline
======================================
$3 BILLION
——————————————————————
7/2/2012
——————————————————————
(4/1998 – 8/2003)
——————————————————————
United States alleges GSK participated in
preparing
publishing
distributing
misleading medical journal article that misreported that clinical trial of drug demonstrated efficacy in treatment when study failed to demonstrate efficacy
——————————————————————
At same time, United States alleges, GSK didn’t make available data from 2 other studies in which drug also failed to demonstrate efficacy
——————————————————————
(2001 – 2007)
——————————————————————
United States alleges GSK failed to include certain safety data about drug in reports to FDA meant to allow FDA to determine if drug continues to be safe for approved indications and to spot drug safety trends
——————————————————————
missing information included data regarding certain post-marketing studies
——————————————————————
data regarding 2 studies undertaken in response to European regulators’ concerns about safety of drug
——————————————————————
United States alleges GSK stated drug had positive cholesterol profile despite having no well-controlled studies to support that message
======================================

======================================
Johnson & Johnson (J&J) and subsidiaries, Janssen Pharmaceuticals Inc. and Scios Inc.
Janssen Pharmaceutica Products, L.P.
======================================
$2.2 BILLION +
——————————————————————
11/4/2013, Monday
——————————————————————
Johnson & Johnson (J&J) and Janssen
——————————————————————
complaint alleges J&J and Janssen were aware drug posed serious health risks, but companies downplayed these risks
——————————————————————
For example, when J&J study of drug showed significant risk of strokes and other adverse events in patients, complaint alleges Janssen combined study data with other studies to make it appear there was lower overall risk of adverse events
——————————————————————
year after J&J received results of 2nd study confirming increased safety risk for patients taking drug, but hadn’t published data, one physician who worked on study cautioned Janssen
——————————————————————
“[a]t this point, so long after [the study] has been completed … we must be concerned that this gives the strong appearance that Janssen is purposely withholding the findings.”
——————————————————————
complaint alleges Janssen knew patients taking drug had increased risk, but nonetheless promoted drug as “uncompromised by safety concerns”
——————————————————————
When Janssen received initial results of studies indicating drug posed same risk as other antipsychotics, complaint alleges company retained outside consultants to re-analyze study results and ultimately published articles stating drug was actually associated with lower risk
——————————————————————
J&J and another of its subsidiaries, Scios Inc.
——————————————————————
8/2001 – FDA approved drug to treat patients with acutely decompensated congestive heart failure who have shortness of breath at rest or with minimal activity
——————————————————————
approval based on study involving hospitalized patients experiencing severe heart failure who received infusions of drug over average 36-hour period
——————————————————————
complaint alleged Scios had no sound scientific evidence supporting medical necessity of outpatient infusions and misleadingly used small pilot study to encourage serial outpatient use of drug
======================================

======================================
Abbott Laboratories Inc.
======================================
$1.5 BILLION
——————————————————————
5/7/2012, Monday
——————————————————————
(2001 – 2006)
——————————————————————
company marketed drug in combination with atypical antipsychotic drugs even after its clinical trials failed to demonstrate adding drug was any more effective than atypical antipsychotic alone for that use
——————————————————————
1999 – forced to discontinue clinical trial of drug due to increased incidence of adverse events, including
somnolence
dehydration
anorexia
experienced by study participants administered drug
——————————————————————
funded 2 studies of use of drug
both failed to meet main goals established for the study
——————————————————————
When 2nd study failed to show statistically significant treatment difference between antipsychotic drugs used in combination with drug and antipsychotic drugs alone, waited nearly 2 years to notify sales force about study results and another 2 years to publish results
======================================

======================================
AstraZeneca LP / AstraZeneca Pharmaceuticals LP
======================================
$520 MILLION
——————————————————————
4/27/2010, Tuesday
——————————————————————
engaged doctors to conduct studies on unapproved uses of drug
——————————————————————
recruited doctors to serve as authors of articles that were ghostwritten by medical literature companies and about studies doctors in question didn’t conduct
——————————————————————
then used
studies
articles
as basis for promotional messages about unapproved uses of drug
======================================
REFERENCE:
======================================
11/26/2013 – United States Department of Justice (DOJ) versus BIG Pharma: BIG Pharma fought the law, and the law won ?:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/11/26/united-states-department-of-justice-versus-big-pharma-big-pharma-fought-the-law-and-the-law-won/
======================================

Count de Money: What Are the Costs of Cancer ? (American Cancer Society Cancer Facts & Figures 2002-2013)

======================================
What Are the Costs of Cancer?
——————————————————————
National Institutes of Health (NIH) estimates:
——————————————————————
overall costs of cancer:
——————————————————————
2010 – $263.8 billion (2011)
2010☝$263.8 billion (2010)
2008👇$201.5 billion (2013)
2008☝$228.1 billion (2009)
2007☝$226.8 billion (2012)
2007☝$219.2 billion (2008)
2006👇$206.3 billion (2007)
2005☝$209.9 billion (2006)
2004☝$189.8 billion (2005)
2003☝$189.5 billion (2004)
2002☝$171.6 billion (2003)
2001☝$156.7 billion (2002)
——————————————————————
direct medical costs
(total of all health expenditures)
——————————————————————
2010 – $102.8 billion (2011)
2010☝$102.8 billion (2010)
2008👇$77.4 billion (2013)
2008👇$93.2 billion (2009)
2007☝$103.8 billion (2012)
2007☝$89.0 billion (2008)
2006☝$78.2 billion (2007)
2005☝$74.0 billion (2006)
2004☝$69.4 billion (2005)
2003☝$64.2 billion (2004)
2002☝$60.9 billion (2003)
2001☝$56.4 billion (2002)
——————————————————————
2008-2011 – indirect morbidity costs
(cost of lost productivity due to illness)
——————————————————————
2010 – $20.9 billion (2011)
2010☝$20.9 billion (2010)
2008☝$18.8 billion (2009)
2007☝$18.2 billion (2008)
2006☝$17.9 billion (2007)
2005☝$17.5 billion (2006)
2004☝$16.9 billion (2005)
2003☝$16.3 billion (2004)
2002👇$15.5 billion (2003)
2001☝$15.6 billion (2002)
——————————————————————
indirect mortality costs
(cost of lost productivity due to premature death)
——————————————————————
2010 – $140.1 billion (2011)
2010☝$140.1 billion (2010)
2008☝$124.0 billion (2013)
2008👇$116.1 billion (2009)
2007☝$123.0 billion (2012)
2007☝$112.0 billion (2008)
2006👇$110.2 billion (2007)
2005☝$118.4 billion (2006)
2004👇$103.5 billion (2005)
2003☝$109 billion (2004)
2002☝$95.2 billion (2003)
2001☝$84.7 billion (2002)
——————————————————————
According to US Census Bureau:
——————————————————————
Americans uninsured
2012-2013 had no health insurance coverage
——————————————————————
2010👇approximately 50 million (2013)
2009 – almost 51 million (2012)
2009☝almost 51 million (2011)
2008☝46 million (2010)
——————————————————————
2008 – approximately 28% aged 18 to 34 years (2010)
——————————————————————
2010👇almost one-third of Hispanics (31%) (2013)
2009 – almost one-third of Hispanics (32%) (2012)
2009☝almost one­-third of Hispanics (32%) (2011)
——————————————————————
2011-2012 (17 years of age and younger)
2010-2012 – had no health insurance coverage
——————————————————————
2010 – one in 10 children (2013)
2009 – one in 10 children (2012)
2009 – one in 10 children (2011)
2008 – 10% of children (2010)
——————————————————————
2012-2013 PLEASE NOTE:

These numbers are not comparable to those published in previous years as of 2011, NIH calculating estimates using different data source:

2012 – NIH is using a different data source:

2012-2013 Medical Expenditure Panel Survey (MEPS) of the Agency for Healthcare Research and Quality

2012-2013 MEPS estimates based on more current, nationally representative data used extensively in scientific publications

2012-2013 direct and indirect costs will no longer be projected to current year, estimates of indirect morbidity costs discontinued

2012-2013 For more information, please visit nhlbi.nih.gov/about/factpdf.htm.
——————————————————————
Lack of health insurance and other barriers prevents many Americans from receiving optimal health care
——————————————————————
2008 – early release estimates from National Health Interview Survey (2009)
2006 – early release estimates from the National Health Interview Survey (2008)
2004 – National Health Interview Survey data (2007)
2003 – National Health Interview Survey data (2006)
——————————————————————
2008 – about 24% aged 18 to 64 years (2009)
2006☝about 24% aged 18-64 (2008)
2004 – about 17% younger than age 65 had no health insurance coverage (2007)
2003☝about 17% younger than age 65 have no health insurance coverage (2006)
——————————————————————
2004 – 27% 65 and older had Medicare coverage only (2007)
2003☝24% 65 and older have Medicare coverage only (2006)
——————————————————————
2008 – 13% of children had no health insurance coverage for at least part of past year (2009)
2006☝13% of children had no health insurance coverage for at least part of past year (2008)
——————————————————————
2008 – More than 36% of adults who lack high school diploma were uninsured in past year (2009)
2006☝Almost 34% of adults who lack high school diploma were uninsured in past year (2008)
——————————————————————
2008 – 23% of high school graduates (2009)
2006☝23% of high school graduates (2008)
——————————————————————
2008👇14% of those with more than high school education (2009)
2006 – 15% of those with more than high school education (2008)
——————————————————————
2008 – Lack of health insurance is not only a concern of unemployed; almost one-quarter of employed individuals (aged 18 to 64 years) were uninsured sometime during past year (2009)
——————————————————————
2004 – Persons in lowest income group 10 times as likely as persons in highest income group not to receive needed medical care because of cost (2007)
——————————————————————
2004 – Almost 16 million citizens (6%) were unable to obtain needed medical care due to cost (2007)
——————————————————————
2003 – In survey, nearly 20% aged 18-44 years reported not having usual place to go for medical care (2006)
——————————————————————
2010-2013 – Uninsured patients and ethnic minorities substantially more likely to be diagnosed with cancer at later stage, when treatment can be more extensive and more costly
——————————————————————
2012-2013 – For more information on relationship between health insurance and cancer, see Cancer Facts & Figures 2008, Special Section, available online at cancer.org/statistics.
2010 – cancer.org.
2009 – (5008.08), Special Section, available online at cancer.org.
2008 – see special section page 22

======================================
REFERENCES:
======================================
2013:
——————————————————————

Click to access acspc-036845.pdf

======================================
2012:
——————————————————————

Click to access acspc-031941.pdf

======================================
2011:
——————————————————————

Click to access acspc-029771.pdf

======================================
2010:
——————————————————————

Click to access acspc-024113.pdf

======================================
2009:
——————————————————————

Click to access 500809webpdf.pdf

======================================
2008:
——————————————————————

Click to access worldcancer.pdf

=====================================
2007:
——————————————————————

Click to access caff2007pwsecuredpdf.pdf

======================================
2006:
——————————————————————

Click to access caff2006pwsecuredpdf.pdf

======================================
2005:
——————————————————————

Click to access caff2005f4pwsecuredpdf.pdf

======================================
2004:
——————————————————————

Click to access CancerRates2004.pdf

======================================
2003:
——————————————————————

Click to access 2003_ACS_Cancer_Facts.pdf

======================================
2002:
——————————————————————

Click to access CancerFacts&Figures2002.pdf

======================================